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ABSTRACT 
 
In the last few years, chromatin states have been characterized with 
great detail and associations between histone modifications, transcription 
and splicing have been reported. Here we took advantage of the huge 
quantity of data being generated by big international consortiums to 
undertake different approaches and study these connections in a genome-
wide level. First we explored transcription of developmental regulated 
genes in the context of chromatin. We found that these genes are 
expressed in the absence of canonically active histone modifications and 
possibly under stronger regulation of transcription factors. In this section 
we also report that strong chromatin marking is associated with stable 
expression and splicing. Since splicing, the process of intron removing 
from pre-mRNAs, can happen co-transcriptionally, in the second part of 
this thesis we aimed to quantify how often this phenomenon was 
happening. Our results demonstrate that the majority of the splicing 
events occur while RNA polymerase II is still transcribing. This evidence led 
us to investigate, in a genome-wide level, the connection between splicing 
and chromatin. We found that, despite having very few exons being 
differentially included between a panel of human cell lines we could 
identify a subset of them whose inclusion level is strongly correlated with 
the presence of some chromatin features. In these exons, increased levels 
of H3K9ac, H3K27ac, H3K4me3, DNase I hypersensitive and transcription 
factor binding are associated with higher exon usage. We also found that 
when in conditions of higher inclusion these exons are also in close 
proximity (either in linear of in the 3D space) of active promoters. These 
observations suggest a functional role for histone modifications and other 
chromatin features that activate transcription in the regulation of splicing 
of exons in their physically proximity. 
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RESUMO 
 
Nos últimos anos foram caracterizados em grande detalhe vários 
estados de cromatina e foram descobertas associações entre modificações 
de histonas, transcrição e splicing. Neste projeto aproveitamos a enorme 
quantidade de dados gerados por grande consórcios internacionais para 
levar a cabo várias estratégias e estudar estas relações à escala do 
genoma completo. Na primeira parte explorámos a transcrição de genes 
regulados durante o desenvolvimento sob o contexto da cromatina. 
Descobrimos que estes genes são expressos na ausência de modificações 
histónicas canonicamente associadas com expressão ativa, estando 
possivelmente sob uma mais forte regulação por parte de factores de 
transcrição. Nesta secção também reportamos que uma forte modificação 
da cromatina se encontra associada com estabilidade de expressão e de 
splicing.  Uma vez que o splicing, o processo da remoção de intrões do 
pre-mRNA, pode acontecer co-transcricionalmente, na segunda seção 
desta tese decidimos quantificar a prevalência deste fenómeno. Os nossos 
resultados demonstram que a maioria dos eventos de splicing ocorrem 
durante o período em que a  RNA polimerase II está a transcrever. Esta 
evidência levou-nos a investigar, à escala do genoma completo, a conexão 
entre splicing e cromatina. Descobrimos que, apesar de poucos exões 
terem os níveis de inclusão regulados entre várias linhas celulares 
humanas, era possível identificar um subgrupo de exões com o nível de 
inclusão fortemente correlacionado com a presença de alguns 
características da cromatina. Neste subgrupo de exões, altos nível de 
H3K9ac, H3K27ac H3K4me2, sensibilidade a DNase I e presença de 
factores de transcrição  estão associado a um aumento do nível de  
inclusão. Também descobrimos que, aquando em condições de maior 
nível de inclusão este subgrupo de exões está em proximidade (tanto a 
nível linear como no espaço 3D) de promotores ativos. Estas evidências 
sugerem um papel funcional das modificações de histonas e outras 
características da cromatina que ativam a transcrição, na regulação do 
processo de splicing de exões na sua proximidade.  
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CHAPTER 1- INTRODUCTION 
 
A. The basics of Pol II transcription 
 
Transcription is the first and most highly regulated step in 
eukaryotic gene expression (Nechaev and Adelman). Polymerase II (Pol II) 
transcription is initiated by activator proteins binding upstream the 
transcription start site (TSS), at the core promoter. A series of protein-
protein interactions result in the recruitment of Pol II and various 
transcription factors (TF). DNA at the TSS starts to be unwounded and the 
active site of Pol II is positioned in the single-stranded DNA template. Early 
elongation starts after the phosphorylation of serine 5 (Ser5) of the 
carboxyl-terminal domain (CTD) of RPB1, the largest Pol II subunit. This C-
terminal domain contains 52 repeats of the amino acid sequence Tyr-Ser-
Pro-Thr-Ser-Pro-Ser, offering multiple possible phosphorylation sites. The 
serine residues are referred to as Ser2, Ser5, Ser7 due to their position in 
this sequence (Corden et al.). Ser2 position is further phosphorylated, 
helping in the recruitment of important factors for transcription elongation 
and giving start to the efficient elongation step. During the transcription 
cycle, Pol II CTD serves as a recruitment platform for a large number of 
factors required for productive elongation and messenger RNA (mRNA) 
processing, including histone modifiers and splicing factors (Smolle and 
Workman). 
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B. Transcription and chromatin 
B.1 Nucleosomes 
 
The nucleosome core particle consists of approximately 147 base 
pairs (bp) of DNA wrapped around a histone octamer – 2 copies of each of 
the core histones H2A, H2B, H3 and H4 – forming one of the most stable 
protein-DNA complexes known. Nucleosome positioning and depletion is 
determined by DNA sequences, histone variants incorporation and 
transcription factors. Although their main function is packaging, 
nucleosomes possess many dynamic proprieties, tightly regulated by 
various protein complexes. Depending on the context, nucleosomes can 
inhibit or facilitate transcription factor binding. Most transcribed genes 
have reduced nucleosome occupancy over their promoters when compared 
to the rest of the genome (Müller and Tora).  
 
B.2 Histone modifications and transcription 
Core histones are globular proteins with a long unstructured N-
terminal tail that can undergo a variety of post-translational modification 
in multiple residues (Figure 1). Such modifications influence chromatin 
structure, the recruitment of other proteins to chromatin (Kouzarides) and  
transcription (Li, Carey, and Workman).  
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In the last few years, histone modification states associated with 
active transcription or silenced chromatin have been characterized with 
great detail (Cheng et al.; Filion et al.). Acetylation (ac) of histone 3 and 
histone 4 (H3 and H4) and methylation (me) of lysine (K) 4 and 36 of H3 
are associated with active transcription and often referred as euchromatin 
modifications. In the other hand, trimethylation of Lysine 9 or 27 are 
normally found in inactive genes or repressed regions and can be termed 
heterochromatin modifications (Li, Carey, and Workman). Distribution 
patterns of histone modifications and their correlation with transcription 
rates can be seen in Figure 2.  
 
Figure 1. Histones can undergo a variety of post-translational 
modifications such as acetylation, methylation or phosphorylation in some 
specific residues of their long N-terminal tails.  
Introduction 
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Nucleosomes are very strong barriers for Pol II transcription (Kireeva 
et al.). Although striking in detail, these well-defined landscapes and 
associations may also be a consequence of the struggle to maintain 
chromatin structure in the transcribed regions during Pol II traversing. 
When transcribing into nucleosome templates, Pol II pauses at certain sites 
with stronger histone-DNA contact. To overcome this barrier, ATP-
dependent chromatin-remodeling complexes are known to act, allowing 
transcription to go through (Carey, Li, and Workman).  
 
Figure 2. Distribution of histone modifications on an arbitrary gene 
and their correlation signs with transcription rates. The curves 
represent the patterns that are determined via genome-wide 
approaches. Adapted from Li et al 2007. 
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B.3 Transcription in the absence of H3K4me3 
 
Modifications occurring in the DNA and histone proteins are seen to 
correlate and maybe even control gene expression by establishing and 
maintaining specific chromatin states (Delest, Sexton, and Cavalli). 
Nevertheless, recent genome-wide studies reported the lack of H3K4me3 
at the TSS of a fraction of the expressed genes in Drosophila Melanogaster 
(Nègre et al.). Even more striking was the finding that cells from the wing 
imaginal disc of Drosophila, carrying a non-methylable residue instead of 
lysine 4, could activate gene expression and respond to the developmental 
signaling pathway (Hödl and Basler). Although widespread it seems that 
the presence of H3 protein species is not essential in fly and 
transcriptional regulation can occur in the complete absence of H3K4me3. 
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C. Pre-mRNA splicing 
C.1 Splicing and alternative splicing 
 
The existence cycle of RNA molecules begins with transcription and 
ultimately ends in degradation. Messenger RNA, the RNA molecule that 
carries the genetic information from DNA to the ribosome, may also be 
processed, depending on the species. After transcription, precursor RNA 
(pre-mRNA), undergoes different modifications such as 5’ cap addition, 
splicing, editing and polyadenylation. Splicing is the process by which 
introns are removed from the nascent pre-mRNA and exons are joined, 
generating the functional mRNA. The majority of pre-mRNAs contain exons 
that can be alternatively included or excluded into the mature mRNA in a 
process called alternative splicing. Exons can be extended or skipped and 
introns can be retained (Figure 3). Alternative splicing is a highly regulated 
mechanism that endows a single gene with the capacity to generate 
multiple RNA molecules, either encoding proteins with different functions 
(Kelemen et al.) or different intergenic long non-coding RNAs (lncRNAs) 
(Derrien et al.). Being splicing a major contributor to protein diversity in 
metazoans, it is estimated that 95% of multi-exon genes undergo 
alternative splicing, sometimes in a tissue-specific manner and/or under 
specific cellular conditions (Pan et al.; Wang and Burge). 
Sequence elements at or near intron/exon borders are recognized 
by the spliceosome, a large and complex molecular machine in charge of 
intron removal. This complex is composed of five small nuclear 
ribonucleoprotein particles (snRNPs) and more than 150 auxiliary proteins 
(Wahl, Will, and Lührmann). The binding of additional trans-acting factors, 
members of the SR protein family (Serine and Arginine rich) and hnRNPs, 
to cis-regulatory sequence elements (splicing silencers and enhancers) 
located in intronic or exonic regions of the pre-mRNA facilitates or 
prevents spliceosome assembly on regulated splice sites (Chen and 
Manley). In this classical view, the combination of all these features, acting 
Introduction 
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in combination on the transcribed pre-mRNA determines the splicing 
outcome (Barash et al.).  
 
 
C.2 Importance of alternative splicing 
 
The overall function of alternative splicing is to increase the diversity 
of the mRNA expressed from the genome. Genome-wide studies indicate 
that coding alternative exons predominantly encode coiled regions on the 
outside of the protein. Alternative exons generally influence local regions 
on the protein surface without changing or disrupting the general 
structure of the protein (Wang et al.; Romero et al.). Evolutionary analysis 
Figure 3. Examples of alternative splicing events. Exons are represented 
by blocks and introns by lines. In orange and green there are the exons or 
portions of exons that can be alternatively included or skipped. In the 
right side there are the 2 possible transcripts coming from each example 
gene, on the left. 
Introduction 
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support this notion, as human-mouse comparison shows that alternative 
exons preserving the open reading frame (ORF) are conserved between 
these species (Zhang, Krainer, and Zhang).  
This doesn’t mean that alternative splicing doesn’t have a function. 
In matter in fact, the amount of alternative splicing increases from 
invertebrates to vertebrates (Kim, Magen, and Ast) and in the latter it’s 
also more rich in genes specific of the immune and nervous system 
(Modrek and Lee). This suggests that alternative splicing is more important 
in more complex systems, where information must be processed 
differently at different times or a higher degree of variety is needed. 
In the other hand, given the generality of alternative splicing events 
it is not surprising that aberrant regulation of the process can lead to 
disease. It is estimated that regulation of splicing could be involved in 15% 
of genetic diseases (Krawczak, Reiss, and Cooper). A single polymorphism 
in an exonic enhancer can cause mis-splicing of exon 18 of BRCA1 and 
lead to cancer (Liu et al.). Other associations with diseases are known, 
either with disrupting of the splicing of specific genes (Bechtel et al.) or 
with general deregulation, in cancer cells (Klinck et al.; Venables et al.). 
Localization and enzymatic proprieties of the proteins can also change due 
to changes in alternative splicing outcome (Kelemen et al.).  
 
 
C.3 Co-transcriptional splicing 
 
Splicing, from the beginning, was defined as a post-transcriptional 
process, well documented in vitro and in vivo (Green, Maniatis, and 
Melton). With the realization that introns could be removed while nascent 
transcripts were still tethered to the DNA a new dimension of alternative 
splicing regulation arose (Beyer and Osheim). Recent evidence, in which 
this research project took part in, changed the paradigm and it is now 
commonly accepted that, in most of the cases, transcription and pre-mRNA 
splicing are an integrated process (Ameur et al.; Dye, Gromak, and 
Introduction 
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Proudfoot; Khodor, Menet, et al.; Khodor, Rodriguez, et al.; Listerman, 
Sapra, and Neugebauer; Pandya-Jones and Black; Tilgner, Knowles, et al.; 
Vargas et al.). 
We know now that splicing is mostly co-transcriptional but we’re still 
trying to understand how both processes are coupled and how can splicing 
and transcription machinery interact. Three aspects, somehow related, of 
co-transcriptional processing can influence alternative splicing regulation. 
First, a kinetic competition between splice sites where a weaker splice site 
can be recognized and used under pausing or slow elongation rates as 
opposed to the stronger splice site, always used, independently of the rate 
of elongation (Roberts et al.). In this model, inclusion levels anti-correlate 
with polymerase speed (Sebastián Kadener et al.; Mata et al.).  
 
Figure 4. Model of alternative splice site events regulated by RNA 
polymerase II elongation rates. In the model, an alternative exon (in dark 
yellow) preceded by a weak splice site is more included when elongation 
rate of RNA polymerase is low (left) and is more skipped when elongation 
rate is faster (right). Slower elongation rates provide more time for 
excision of the intron upstream of the alternative exon before its splice 
site enters in competition with the splice site of the downstream exon. 
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Second, if splicing can take place while RNA and DNA molecules are 
still attached to Pol II, the latter can play a role in splicing regulation. In 
particular the CTD of Pol II is known to interact with a variety of 
transcription and splicing regulators. For example, transcription 
termination and 3’ end processing depend on the CTD-domain of Pol II 
(McCracken et al.), hinting that these processes not only occur in physical 
proximity to transcription, but that there could be a functional connection. 
Third, given the intimate relationship between transcription regulation and 
chromatin structure, already for some time, models for splicing regulation 
by chromatin had been proposed. Recently, with the advent of massively 
genome wide sequencing, the resolution for nucleosome and histone 
modification profiling has substantially increased allowing us for the first 
time to compare signal in exons versus introns, for example. Cases of 
direct chromatin–splicing interactions have been reported: a subunit of the 
chromatin remodeling complex SWI/SNF regulates splicing (Batsché, Yaniv, 
and Muchardt) and many different histone modifications were already 
implicated in splicing regulation (Alló et al.; Nogues et al.; Schor et al.; 
Sims et al.; Luco, Pan, et al.).  
 
  
C.4 Nucleosome organization on exons 
 
Vertebrates’ exon size, in contrast with the much longer and 
variable intron size, seems to be under strong evolutionary constraint 
remaining at a small range around 140 base pairs (Wang and Burge). 
Already in 1991, Beckmann and Trifonov noticed a periodic pattern 
between splice sites, compatible with nucleosome phasing (Beckmann and 
Trifonov). They hypothesized the presence of a nucleosome could protect 
splice sites from mutational hazards.  
Micrococcal nuclease digestion (MNase) of chromatin followed by 
high-throughput DNA sequencing revealed that, indeed, regions protected 
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from nuclease digestion are enriched in exons over introns. This 
confirmed that nucleosomes are preferentially positioned in exons and 
supports the protective role of nucleosomes, mentioned above. This is a 
phenomenon evolutionary conserved (Hodges et al.; Nahkuri, Taft, and 
Mattick; Schwartz, Meshorer, and Ast; Spies et al.; Tilgner, Nikolaou, et al.). 
Several other correlative features argue in favor of a functional role of 
nucleosomes in splice site recognition and exon definition. Isolated exons 
flanked by long introns have higher nucleosome occupancy than clustered 
exons with small introns (Spies et al.). Exons with weaker splice sites have 
stronger nucleosome occupancy, suggesting that well-positioned 
nucleosomes can be key in the recognition of weak splicing signals 
(Tilgner, Nikolaou, et al.; Schwartz, Meshorer, and Ast). Nucleosome 
occupancy in exons is independent of the transcription level (Tilgner, 
Nikolaou, et al.) and is enhanced in highly included versus highly excluded 
exons (Spies et al.). Pseudoexons (intronic sequences with well-defined 
splice site sequences that are not included in mature transcripts) show, 
inversely, a depletion of nucleosomes (Tilgner, Nikolaou, et al.). And lastly, 
nucleosome enrichment is present, independently of sequence 
conservation or GC- content although the strength of nucleosome 
occupancy is correlated with GC-content levels (Nahkuri, Taft, and Mattick; 
Schwartz, Meshorer, and Ast; Tilgner, Nikolaou, et al.). 
 
 
C.5 Histone modifications on exonic regions 
 
Genome-wide experiments, in particular chromatin 
immunoprecipitation followed by sequencing (ChIPSeq), allowed the study 
of histone modifications and variations in genomic regions. Preferential 
accumulation of particular histone modifications was found in exons over 
introns (Andersson et al.; Kolasinska-Zwierz et al.; Schwartz, Meshorer, 
and Ast; Spies et al.). H3K36me3 (and H3K79me1 in a less pronounced 
way) levels are known to increase towards the 3’ end of genes and to 
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correlate with expression (Figure 2).  However, inside the genes, the 
profiling revealed enrichment in exons versus introns, with stronger signal 
in constitutive ones. This was initially discovered in C. Elegans and later 
extended to human and mouse) (Andersson et al.; Dhami et al.; 
Kolasinska-Zwierz et al.). Internal exons are also marked by H3K27me2 
while H3K27me1 and H3K4me1 signal appears enriched only in internal 
exons flanked by long introns (Spies et al.). Introns were also described as 
carrying monoubiquitination of histone 2B marking (Dhami et al.; Shieh et 
al.). 
When looking at exonic regions, one needs to be careful by the 
increased nucleosome occupancy. Although in some cases is difficult to 
distinguish histone modification enrichment from nucleosome enrichment, 
some studies showed that the enrichment of histone modifications present 
in exons could not be explained by the consequence of having a higher 
density if nucleosomes. H3K36me3, H3K4me3 and H3K27me2 maintain 
their enriched profile in exons over introns even after nucleosome 
normalization (Dhami et al.; Spies et al.; Kolasinska-Zwierz et al.). 
Since histone modifications profoundly influence chromatin 
accessibility (Kouzarides), they have been hypothesized to influence splice 
site recognition and usage too. 
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D. Intragenic chromatin organization and splicing 
 
As splicing knowledge grew, it became clear that regulation and 
splice site selection is a far more complex process than it was anticipated. 
RNA-binding factors and RNA Pol II elongation rate are not sufficient to 
fully explain the faithful regulation of alternative splicing. RNA-binding 
motifs are not conserved between genes and even when they are 
transcribed with errors, they can still often recruit the appropriate set of 
splicing factors (Fox-Walsh and Hertel). Similarly, although Pol II elongation 
rate are known to affect splicing outcome in different scenarios (Mata et 
al.; Muñoz et al.) it is still unclear if this is  a commonly used mechanism 
in vivo. Taken the observations in Section C all together, it was natural that 
many authors started raising the possibility of having chromatin 
organization as a key regulator in RNA processing and more specifically, in 
alternative splicing.  
The first evidence of an interplay between chromatin structure and 
splicing came from the finding that fibronectin exon 33 inclusion or 
exclusion was sensitive to replication-mediated chromatinization status of 
the plasmid and to histone deacetylase inhibitor TSA (Sebastian Kadener et 
al.; Nogues et al.). The recent advent of methods to study chromatin 
structure in a genome-wide scale revealed association between histone 
modifications and transcript diversity (Podlaha et al.) and many specific 
connections that essentially can be categorized in two, not mutually 
exclusive, models (Figure 5): The “kinetic model” that proposes regulation 
of splicing outcome by using nucleosome position and/or histone 
modifications as a proxy for modulating RNA polymerase II elongation rate 
(Kornblihtt et al.) and the “recruitment model” that argues for direct 
recruitment of splicing factors on the nascent pre-mRNA by histones and 
their modifications in a chromatin-splicing adaptor system (Luco, Pan, et 
al.).  
All together it seems natural to speculate that chromatin regulators, 
able to read the “histone code”, may be helping splicing machinery to 
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locate and access pre-mRNA and therefore, regulating splicing in addition 
to all the long time known players. 
 
D.1 Chromatin, elongation rate and splicing 
 
One of the mechanisms by which the transcription machinery can 
influence splicing is the called “kinetic coupling model”. In this model, the 
rate of Pol II elongation influences the splicing outcome by affecting the 
pace at which splice sites and regulatory sequences emerge and are made 
available in the nascent pre-mRNA, during transcription. This model 
became popular when the nature of the promoter, and consequent 
elongation rate, was discovered to influence alternative splicing outcome 
(Cramer et al.; Kornblihtt). The result was not a consequence of promoter 
strength but of some qualitative properties conferred by promoters to the 
transcription machinery. Several other lines of evidence support the idea 
that RNA Pol II elongation can affect alternative splicing through kinetic 
coupling. Inhibiting histone deacetylation and therefore promoting “open 
chromatin” by trichostatin A (TSA) leads to more skipping of the exon 33 
(E33) of fibronectin (Sebastian Kadener et al.). On the other hand, drugs 
inhibiting elongation, like DRB (Sebastian Kadener et al.; Nogues et al.), 
flavopiridol, or camptothecin (de la Mata, Lafaille, and Kornblihtt) favor 
inclusion. However, the strongest evidence for a kinetic role of Pol II 
elongation comes from a slow mutant Pol II, which increases the same 
exon 33 usage in human cells when compared to the normal rate 
polymerase (Mata et al.). 
Another very interesting finding came from the study of the DNA-
binding protein CCCTC-binding factor (CTCF), a genomic insulator. CTCF 
was described to create a “roadblock” to Pol II elongation downstream the 
exon 5 of CD45, promoting its inclusion (Shukla et al.). Additionally, DBIRD, 
a two-subunit complex that interacts with RNA polymerase II and nascent 
ribonucleoprotein complexes (mRNPs), which promotes RNA Pol II 
elongation through A-T rich regions (particularly difficult for Pol II to 
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transcribe) was reported to facilitate skipping of alternative exons within 
these regions (Close et al.). 
Since nucleosomes represent physical barriers for the progression of 
RNA polymerase complex they also have the capacity to modulate 
transcription elongation rates. In recent studies, Pol II was reported to 
pause at nucleosomes (Churchman and Weissman; Kwak and Lis) and at 
the 3’ end of introns (Kwak and Lis) which is consistent with the higher 
nucleosome density in exons, described before. Moreover, Brahma (Brm) 
and Brg1, protein components of the SWI/SNF chromatin remodeling 
complex that can influence nucleosome occupancy, were found to 
associate with regulators of the spliceosome, slowing down polymerase II 
and favoring inclusion of alternative exons (Batsché, Yaniv, and Muchardt). 
This chromatin binding is in part mediated by a bromodomain that 
recognizes acetylated histones (Agalioti, Chen, and Thanos). Histone 
acetylation was also implicated in splicing regulation in a more 
physiological context by Schor et al., in 2009. Upon neuron membrane 
depolarization, acetylation of H3K9 is increased around exon 18 of the 
Neural Cell Adhesion Molecule (NCAM) gene but not in its promoter. Exon 
18 is also reported as more skipped while Pol II elongation rate is 
increased (Schor et al.). All this evidence is compatible with the kinetic 
model of splicing regulation (Figure 5a). 
On the other hand, a recent study showed that a slow Pol II could 
also induce skipping of exons. In CFTR gene, skipping of exon 9 is 
promoted by a slow elongation rate through the recruitment of the 
negative splicing factor ETR-3 onto de uridine and guanosine (UG) repeat 
located at the neighbor intron (Dujardin et al.). 
 
 
D.2 Chromatin-splicing adaptor system 
  
In the chromatin context, adaptor molecules are molecules that 
recognize specific epigenetic marks and interact with factors and enzymes 
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involved in chromatin modifications. In transcription regulation the role of 
adaptor molecules is very well documented (Li, Carey, and Workman; Ries 
and Meisterernst). The protein MRG15 was one of the first published 
evidences of a molecule with a similar role in splicing regulation. MRG15 
recognizes H3K36me3 and interacts with the splicing regulator 
Polypyrimidine Tract Binding protein (PTB) regulating splicing of the gene 
FGFR2 (Luco, Pan, et al.). Exon IIIb of FGFR2 is used in epithelial cells while 
exon IIIc is included in mesenchymal cells instead.  Interestingly these two 
cell types display differences in histone modification profiles of this region. 
High levels of H3K36me3 and H3K4me1 in the first, correlating with usage 
of exon IIIb and high levels of H3K27me3 and H3K4me3 in the second, 
correlating with usage of exon IIIc. High levels of H3K36me3 along the 
alternatively spliced region of the gene attract MRG15, which in turn 
interacts with PTB, recruiting it to the nascent RNA and promoting 
inclusion of exon IIIb and exclusion of exon IIIc. In contrast, in cell types 
where H3K36me3 levels are low, the splicing repressor PTB is poorly 
recruited to the region and, as a consequence, inclusion of PTB-dependent 
exons favored (Figure 5b). Increasing H3K36me3 levels in the absence of 
MRG15 protein have no effect on alternative splicing. Importantly, 
genome-wide analyses uncovered an inverse correlation between 
alternatively spliced exons affected by MRG15 and the strength of PTB 
binding sites in the target pre-mRNA (Luco, Pan, et al.) showing that 
histone modification regulation is particularly important when the intrinsic 
binding signal is weak, strengthening its effect. 
There is evidence of more chromatin-splicing adaptor systems in 
mammalian cells. H3K4me3 levels play a role in recruitment of the early 
spliceosome to human cyclin D1 pre-mRNA via binding of the chromatin-
adaptor protein CHD1, increasing splicing efficiency (Sims et al.). CHD1 is 
a chromodomain protein that recognizes H3K4m3 and interacts with SF3a, 
a sub complex of the U2 snRNP involved in early 3’ splice site recognition. 
CHD1 is also a component of the histone acetyltransferase SAGA complex 
with which Gcn5 (which binds to acetylated H3) also interacts, recruiting 
U2 snRNP components to the exon (Gunderson and Johnson).  HP1 protein, 
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a characteristic heterochromatin component, might be another example. 
Mass spectrometry identified H3K9 trimethylation, HP1 proteins and 
splicing factors SRp20 and AS/SF2 as interaction partners (Loomis et al.). 
Co-immunoprecipitation experiments confirmed that HP1β interacts with 
splicing factors ASF/SF2 in humans (Loomis et al.) and HP1α with hnRNP 
proteins in Drosophila (Piacentini et al.). It was observed that depletion of 
the HP1α (CBX) isoform is associated with accumulation of unspliced 
nascent transcripts and deficient recruitment of splicing factors 
(Smallwood et al.).  These results point to a possible role for HP1 as an 
adaptor between heterochromatin marks and splicing factors although the 
functional relevance to splice site selection remains to be determined. 
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a) 
b) 
 
 
Figure 5. Two known models for splicing regulation by histone 
modifications. In the kinetic model (a) histone modifications (in the 
example H3K9ac/me) can modulate the speed of polymerase and 
determine the inclusion/skipping of weak splice sites. In the 
recruitment model (b) an adaptor protein (MRG15 in the example) 
recognizes H3K36me3 and interacts with a splicing factor (PTB) 
promoting exon skipping 
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E. Splicing reaches back 
 
Although the mechanisms postulated so far describe only the effects 
of chromatin organization on RNA polymerase elongation and recruitment 
of splicing factors there is also recent evidence of an interaction loop 
where the recruitment of the splicing machinery can also influence 
chromatin structure/dynamics and transcription and therefore modulate 
splicing through these effects (de Almeida and Carmo-Fonseca). 
Splicing was first suggested to enhance transcription by Fong and 
Zhou, who found that spliceosomal snRNPs interact with the transcription 
elongation factor TAT-SF1. TAT-SF1-snRNP complexes can stimulate 
transcription elongation in vitro in a splice site dependent manner (Fong 
and Zhou). Splice sites were also reported to cause stalling of polymerase 
when mutated (Martins et al.) and in terminal exons in yeast (Carrillo 
Oesterreich, Preibisch, and Neugebauer). In Saccharomyces cerevisiae, 
RNA polymerase II was found to accumulate transiently around 3’ end of 
introns. This apparent pausing coincides with splicing factor recruitment 
and it terminates upon appearance of spliced products (Alexander et al.). 
These findings suggest that intron removal is required for transcription 
termination and pausing, in turn, could be part of a proofreading 
mechanism for correct mRNA production. 
Splicing regulatory Hu proteins can also influence transcription 
changes by modulating chromatin structure (Zhou et al.). Hu proteins are 
recruited to pre-mRNA and can induce local histone hyper acetylation in 
regions surrounding alternative exons by inhibiting histone deacetylase 2 
(HDAC2). Therefore chromatin remains hyper acetylated after the first 
passage of polymerase and local elongation rate is increased in later 
passages leading to decreased exon inclusion. 
More evidence of chromatin modulating splicing activity was 
reported by Karen-Shaul et al. Using a plasmid reporter it was shown that 
strengthening 5’ splice site increases inclusion of the alternative exon but 
also nucleosome density in the region (Keren-Shaul, Lev-Maor, and Ast). 
Similarly, levels of H3K36me3 can be affected by splicing activity as 
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illustrated by the effects of 3’ splice site mutation or by inhibiting splicing 
using antitumor drug Spliceostatin A (Kim et al.), which binds to and 
inhibits components of U2 snRNP (Bonnal, Vigevani, and Valcárcel). 
Mechanistically, splicing can alter H3K36me3 levels by favoring the 
recruitment of the HYPB/Setd2 methyltransferase to the CTD of the RNA 
polymerase II (de Almeida et al.). 
In conclusion, all the evidence points to a model where splicing 
impacts transcription and chromatin and both of them can feed back to 
splicing too. Splicing decisions appear to be guided by a very complex 
regulatory network, containing both feed forward and feedback circuits (de 
Almeida and Carmo-Fonseca). 
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CHAPTER 2 - OBJECTIVES 
 
Eukaryotic genomes are packaged into chromatin, a highly regulated 
organized structure consisting of DNA and histone proteins. All nuclear 
steps of transcription take place in the context of chromatin and histone 
modifications have been, for a long time, associated with expression levels.  
Evidence still remains correlative and recent studies showed that 
such relationships were actually not essential. Also, with the contribution 
of this thesis to the discovery that splicing mostly occurs co-
transcriptionally, new steps of RNA production started being study in the 
context of chromatin as well. In this thesis work we aim to: 
 
1. Describe developmentally regulated genes and their particular 
chromatin organizations 
 
2. Describe co-transcriptional spliceosome assembly and to quantify 
the fraction of exons that are co-transcriptionally spliced 
 
3. Identify, across multiple cell lines, exons with differentially splicing 
usage and new connections between chromatin and splicing in a 
genome-wide level 
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CHAPTER 3 – RESULTS 
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Abstract 
The interplay of active and repressive histone modifications at 
promoter regions is assumed to play a key role in the regulation of gene 
expression. In contrast to this generally accepted model, we show that 
activation of genes regulated during metazoan development occurs in the 
absence of canonically active histone modifications, while strong 
chromatin marking is associated to transcriptional stability and tighter 
regulation of splicing. Consistently, promoters of developmentally 
regulated genes have a characteristic architecture that globally 
differentiates them from promoters of stably expressed genes. Our results 
support a model in which chromatin marking is associated to stable, 
tightly controlled production of RNA, while unmarked chromatin would 
permit rapid gene activation and de-activation during development. In 
these genes, Transcription Factors binding to chromatin would play a 
comparatively more important regulatory role. 
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Introduction 
Epigenetic modifications in chromatin, including post-translational 
modifications of histone tails, are associated to the differential production 
of RNA that underlies cellular differentiation. Based mostly on the 
cumulative observation of the behavior of individual genes, an 
evolutionary conserved “histone code” governing differential gene 
expression has emerged1. Trimethylation of histone H3 at lysine 4 
(H3K4me3) and at lysine 36 (H3K36me3), for instance, correlate with 
activation of transcription, whereas H3K9me3 and H3K27me3 are usually 
linked to transcriptional repression2, 3. The combinatorial behavior of 
histone modifications along regulatory regions—reflecting and/or 
influencing the specific arrangement of Transcription Factors (TFs) and 
other regulators—would modulate the expression levels of genes, 
conferring them with a unique temporal and spatial transcriptional 
program. Indeed, computational models have been developed that can 
predict gene expression from modification levels of histones in regulatory 
regions with great accuracy4, 5.  
 
A number of recent reports, however, indicate that expression of 
certain genes may occur in the absence of histone modifications 
canonically associated to active genes. The modENCODE project reported 
that a fraction of expressed genes lacked H3K4me3 at their annotated TSS6. 
Hödl and Basler described transcription without H3K4 methylation in the 
wing imaginal disc7. These authors found that cells that code for a non-
methylable residue, instead of lysine 4, are competent to respond to 
developmental signaling pathways by activating target gene expression. 
Chen et al. also observed that pre-midblastula transition (pre-MBT) genes 
tend to have particularly low levels of H3K4me3, even when pre-MBT genes 
continue to be transcribed during the MBT8. More recently, Zhang et al. 
reported that genes located within yeast heterochromatic regions can be 
transcribed in absence of active histone marks9. Since regulated activation 
and de-activation of genes is particularly relevant during morphogenesis, 
here we investigated the relationship between histone modifications and 
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gene expression along development. Thus, we analyzed data produced by 
the modENCODE project in whole animals and tissues and characterized 
the fly transcriptome by RNASeq and the epigenome by ChIPSeq in two 
spatially well-defined and relatively homogeneous tissues: Wing and Eye-
antenna imaginal discs. Finally, we carried out targeted experimental 
validations in isolated cells. Our analyses strongly suggest that activation 
of genes regulated during fly development can occur in the absence of the 
chromatin marks typically associated with gene activation. They also 
indicate that strong chromatin marking is associated not only to elevated 
transcriptional levels but also to stability in RNA production, both at the 
transcriptional and post-transcriptional levels.  
 
 
Results 
Expression without activation-associated histone modifications 
in genes regulated during development 
To investigate the dynamics of chromatin marking in 
developmentally regulated genes, compared with that of genes stably 
expressed during development, we analyzed data produced within the 
Drosophila melanogaster modENCODE project6, 10. We specifically analyzed 
RNASeq data and ChIPSeq data for H3K4me3, H3K9ac, H3K4me1, H3K27ac, 
H3K27me3 and H3K9me3 on whole animals (Supplementary Fig. 1a). To 
measure transcriptional stability, we computed the coefficient of variation 
(cv) of gene expression over 12 developmental time points (Methods and 
Supplementary Fig. 1b). The cv distribution uncovers a large class of genes 
with low coefficient of variation, and that therefore show constant 
expression during development, and two other minor classes containing 
genes whose expression is highly variable during development—often 
restricted to a limited number of stages (Supplementary Fig. 1c, d). We 
arbitrarily selected the 1,000 genes with the highest coefficient of 
variation as developmentally regulated genes and matched them with the 
1,000 genes with the lowest coefficient of variation as developmentally 
stable. For each gene, we determined the time point at which its 
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expression is maximal. At this time point, we did not observe differences 
between the expression of stable and regulated genes (Fig. 1a).  Next, at 
the same time point, we measured the levels of the monitored histone 
modifications by specifically computing the height of the highest peak 
(measured as the log of the number of ChIPSeq reads reported by the 
modENCODE project) within the gene bodies. At the point of maximal gene 
expression, stable genes are strongly marked by histone modifications 
typically associated to transcription initiation: H3K4me3 and H3K9ac, and 
also by the enhancer modifications H3K4me1 and H3K27ac. Unexpectedly, 
however, developmentally regulated genes show very low levels of these 
modifications, which are comparable to those of silent genes (Fig. 1b, 
Supplementary Fig. 2). In Figure 1c we compare the pattern of H3K4me3 
along fly development in CG8636, a gene stably expressed during 
development, and in CG16733, a gene specifically expressed in pupa. 
CG8636 shows a strong H3K4me3 peak downstream from the 
Transcription Start Site (TSS), whereas CG16733 lacks any marking, even at 
the pupa stage, where it is expressed at higher levels than CG8636. Lack 
of marking cannot be generally attributed to restricted expression patterns 
in regulated genes, since marking can still be detected in stable genes 
with restricted expression patterns (Supplementary Fig. 3). This 
contrasting pattern of histone marking is not only apparent when 
comparing genes with extreme behavior, but it is actually a distinct feature 
of the partition of the entire set of fly genes in two major classes 
according to transcriptional stability (Supplementary Fig. 4). For the 
repressive marks H3K27me3 and H3K9me3 we computed the average 
signal over the gene body and observed that regulated genes showed 
higher levels than stable ones, and at similar levels, even slightly higher, 
than silent genes (Fig. 1d). The difference of repression-associated marks 
between stable and silent genes is, however, small compared with the 
differences observed for active marks.  This is partially due to a large 
proportion of silent genes lacking any evidence of these marks 
(Supplementary Fig. 5)11. 
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To investigate whether lack of chromatin marking is a general 
feature of developmentally regulated genes across metazoans, we 
analyzed in a similar way C. elegans modENCODE data. We used RNASeq 
based gene expression obtained on seven time points through C. elegans 
development12 and ChIP-chip data on the two histone modifications 
available for all these time points: H3K4me3 and H3K36me3. Given the 
smaller number of available developmental time points, we have employed 
a stricter criterion, and considered only the 250 genes with the lowest 
coefficient of variation as developmentally stable genes, and the 250 
genes with the highest coefficient as developmentally regulated genes. 
While both, the temporal resolution and the reliability of the chromatin 
data obtained through ChIP-chip rather than ChIPSeq, are lower in worm 
than in the fly, we observed a similar trend: the expression level at the 
time point of maximum expression is very similar in worm regulated and 
stable genes (Fig. 2a), while regulated genes show much lower levels of 
H3K4me3 and H3K36me3, and comparable in the latter to those of silent 
genes (Fig. 2b). 
 
Given that developmental chromatin maps produced in the 
modENCODE project are on whole organisms, it could be argued that 
apparent lack of chromatin marking is the consequence of the expression 
of developmentally regulated genes being spatially confined to specific 
domains, which would make it undetectable using current technologies. 
While, indeed, developmentally regulated genes show in general a spatially 
restricted pattern of expression, chromatin marking can actually be 
detected in stable genes that exhibit also a restricted expression pattern 
comparable to that in regulated genes (Supplementary Fig. 3). To further 
rule out this possibility we used tissue-specific RNASeq data recently 
released by the modENCODE fly project. Data currently available include 
tissues from a few developmental and adult time points13. Third instar 
larva (L3) is the time point with the larger number of tissues available: 
Carcass, Central nervous system, Digestive system, Fat body, Imaginal 
discs and Salivary glands. Collectively, they comprehend most of the 
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animal body at this developmental time point. Using L3 tissue-specific 
RNASeq data, we identified seven developmentally regulated genes 
(Supplementary Fig. 1c) that are expressed in all six available tissues at L3 
(“Regulated broadly expressed” Fig. 3a, left panel). Conversely, we 
identified 130 stable genes that are specifically expressed in only one of 
the aforementioned tissues in L3 (“Stable tissue-specific”, Fig 3a, right 
panel). Regulated broadly expressed genes have much higher expression 
levels than stable tissue specific genes when measured in the whole body 
(almost four-fold, Fig. 3b), as well as, in general, when measured on 
individual tissues (Supplementary Fig. 6).  They have also higher 
expression levels than stable genes overall. We confirmed the expression 
of these genes by q-PCR (Fig. 3b). However, their H3K4me3, H3K9ac, 
H3K4me1, and H3K27ac levels are comparable to those in genes silent at 
L3, and significantly lower than in stable genes, and even than in stable 
tissue specific genes (Fig. 3c).   We confirmed the levels of the 
transcription initiation marks H3K4me3 and H3K9ac by individual ChIP-
qPCR (Fig. 3d). 
 
All these results strongly suggest that activation of developmentally 
regulated genes occurs mostly in absence of histone modifications 
canonically linked to active genes. They also suggest that strong 
chromatin marking is associated not only to transcriptional levels, as 
generally accepted, but also to transcriptional stability. To explore this 
hypothesis, we computed the correlation in stable genes between the 
coefficient of variation (cv)—as a measure of transcription stability: lower 
cv, higher stability—and the average marking by histone modifications. For 
all active histone modifications, the correlation is negative and significant 
(as low as -0.4 for H3K4me3, Supplementary Table 2a), and comparable in 
magnitude to the correlation between gene expression and histone 
modifications (which is 0.4 for H3K4me3, when computed on averages 
along all developmental time points). The effect is even stronger when 
considering the entire set of genes, and not only the stable ones, although 
in this case, the results can be confounded by the more restricted 
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expression pattern of regulated genes (Supplementary Table 2a). The 
effect is not an indirect consequence of a potential correlation between 
transcriptional levels and transcriptional stability, since it remains when 
controlling for transcriptional levels using partial correlations 
(Supplementary Table 2b).  
 
Gene expression without activation-associated histone 
modifications in imaginal discs  
Data generated by the modENCODE project monitors complex systems 
encapsulating great cellular heterogeneity. To investigate the dynamics of 
chromatin marking during development in a more homogeneous cellular 
environment, we characterized the transcriptome by RNASeq 
(Supplementary Fig. 7a, b and Supplementary Table 1) and the epigenome 
by ChIPSeq in two D. melanogaster third instar larval tissues: Wing and 
Eye-antenna imaginal discs (WID and EID, respectively). We specifically 
monitored H3 and the active marks performed by modENCODE H3K4me3, 
H3K9ac, H3K4me1, and H3K27ac, plus the transcription elongation mark 
H3K36me3 (Supplementary Fig. 7c) Both, WID and EID, are tissues in early 
differentiation from epithelial origin, and differentially expressed genes 
are likely to be under developmental control. While WID and EID 
transcriptomes and epigenomes are very similar (Supplementary Fig. 7c-e), 
differentially expressed genes do exhibit functions strongly consistent 
with the known biology of these tissues (Supplementary Fig. 7f).  
 
We then investigated the marking of regulated and stable genes in WID 
and EID. To further focus on genes under stronger regulation, we 
identified 55 developmentally regulated genes expressed in EID, but not in 
WID and 10 regulated genes, expressed in WID but not in EID. We also 
identified a set of 284 stable genes highly expressed both in EID and WID, 
as well as a set of 30 genes silent in both. (Supplementary Tables 3-8 and 
Methods).  
 
Results – Part I 
 
 41 
We next compared marking of stable, silent, and regulated WID- and EID-
specific genes (simply, WID- and EID-specific). The WID- and EID-profiles of 
stable genes are very similar, as there are those of silent genes (Fig. 4a), 
which is consistent with previous observations11, 14. Stable and silent genes 
are both characterized by higher stable nucleosome occupancy than 
nearby intergenic regions, but the genic nucleosome enrichment (the H3 
profile) is larger for stably expressed than for silent genes. Stable genes 
are also strongly marked by the transcription initiation modifications 
H3K4me3 and H3K9ac, the elongation modification H3K36me3, and also, 
as observed in modENCODE, by H3K4me1 and H3K27ac. Silent genes 
mostly lack these histone modifications. Tissue-specific genes exhibit, 
however, a contrasting behavior. As expected, WID-specific genes lack 
H3K4me3, H3K9ac, H3K36me3, H3K4me1 or H3K27ac modifications in 
EID (Fig. 4b), and EID-specific genes are not marked in WID (Fig. 4c). 
Unexpectedly, but consistently with the behavior previously observed in 
modENCODE data, WID-specific genes are not marked in WID either, nor 
EID-specific genes in EID. Absence of active histone marking cannot be 
attributed to the lack of nucleosomes because a clear H3 signal is 
observed in these genes (Fig. 4b, c). Lack of histone marking is not due, 
either, to the relative low level of expression of WID- or EID-specific genes, 
since even for WID- or EID-specific genes with high levels of expression, 
comparable to those of constitutively expressed genes, there is no 
marking by H3 modifications associated to gene activation. This is 
explicitly illustrated in Figure 5 (see Supplementary Fig. 8 for more 
examples). WID-specific CG4382 gene and EID-specific CG14516 gene have 
similar levels of expression than the stable gene noc. This gene, however, 
is strongly marked by histone modifications in both WID and EID, while 
CG4382 and CG14516 are marked in neither. Lack of chromatin marking 
cannot be attributed to the restricted expression of tissue-specific genes, 
since the expression of noc is also restricted to specific regions both in 
WID and EID15, 16. H3 levels of tissue specific and stable genes are 
comparable and only depend weakly on the expression status of genes 
(Fig. 5).  
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Developmentally regulated genes are actively transcribed in the 
absence of activation-associated histone modifications  
While WID and EID are relatively homogeneous tissues, they already show 
some cellular sub-specialization at third instar larvae. For instance, the 
WID-specific gene Pdm2, like nubbin (nub)17, with strong temporal and 
spatial regulation during development, is only expressed in the wing 
primordium (wing pouch) at third instar larva (Fig. 6a). To unequivocally 
demonstrate lack of chromatin marking in developmentally regulated 
genes, we took advantage of the existence of the nub-GAL4 driver to drive 
expression of GFP only in the wing pouch, where Pdm2 is expressed. Thus, 
we collected all cells expressing Pdm2 and investigated chromatin marking 
for this gene only in the cells in which it is expressed. More specifically, 
dissection and dissociation of wing discs followed by cell-sorting analyses 
allowed the isolation of two populations of cells: the wing pouch (nub 
domain, GFP positive) and the rest of the wing (GFP negative) (Fig. 6a and 
Methods). By using qPCR we found that the expression of Pdm2, restricted 
to sorted GFP positive cells, is even higher than the expression of crm, a 
gene expressed at the same level throughout the WID (Fig. 6b). ChIP 
assays followed by qPCR on sorted cells showed that the levels of the 
transcription initiation mark H3K4me3, and the transcription elongation 
mark H3K36me3 in Pdm2 are significantly lower than in crm, and 
comparable to those in CG10013, a gene silent in the whole WID (Fig. 6c).  
 
While qPCR shows high levels of Pdm2 in the wing pouch (Fig. 6b), 
RNA levels do not necessarily demonstrate active transcription, since the 
detected RNA molecules could have been transcribed at an earlier time 
point. As a measure of active gene expression we directly measured newly 
transcribed RNA (nascent RNA) in sorted cells. As shown in Figure 6d, 
Pdm2 active transcription in GFP positive cells is as high as transcription of 
the control gene crm. Pdm2, therefore, is actively transcribed in the 
absence of active chromatin modifications. 
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Developmentally regulated genes exhibit characteristic promoter 
architecture 
The striking differences in chromatin landscape between 
developmentally regulated and stable genes suggest that these two sets of 
genes may be under globally different transcriptional regulatory programs. 
Thus, we specifically analyzed the promoters of modENCODE stable and 
regulated genes. First, we found that the promoter sequence of 
developmentally regulated genes is significantly more conserved across 
the Drosophila genera than that of stable genes (average PhastCons19 score 
of 0.27 compared to 0.17, Fig. 7a), suggesting that promoters of regulated 
genes are under stronger selective constraints than those of stable genes. 
Similar observations have been reported in mammals20. Conservation is 
particularly strong in predicted Transcription Factor (TF) Binding (TFB) 
motifs, with an average of 30 conserved motifs in the promoters of 
regulated genes compared to only 18 in stable genes (Fig. 7a). In addition, 
we found an enrichment of DNA Replication related Element (DRE) 
sequences, which are associated to disperse initiation of transcription, in 
promoters of stable genes. Conversely, promoters of developmentally 
regulated genes presented a strong overrepresentation of TATA Binding 
Protein (TBP) boxes, which are characteristic of tighter gene regulation21, 22 
(Fig. 7b). Consistently, we also found that promoters of stable genes 
overlap modENCODE High Occupancy Target (HOT) regions, associated to 
open chromatin and ubiquitous expression23, 24, more often than promoters 
of regulated genes (67% vs. 8%). The evidence that developmentally 
regulated genes may be under a globally different transcriptional 
regulatory program than stable genes is further supported by analysis of 
ChIP-chip data available through the modENCODE project on 20 TFs at 
embryo 0-12 hours6. When using Principal component analysis (PCA) to 
classify genes expressed at this time point based on the ChIP-chip binding 
profiles at their promoters, a clear separation between developmentally 
regulated and stably expressed genes appears  (Fig. 7c).  
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Lack of active chromatin marks is a genomic property of 
developmentally regulated genes independent from cell state 
A number or recent reports, using complementary approaches, have 
described the existence of large domains underlying chromatin 
organization in the fly genome25, 26. Filion et al.27, in particular, used 
integrative analysis of genome-wide maps of 53 chromatin components in 
the embryonic cell line Kc167 to segment the Drosophila genome in five 
main chromatin types. One of these types, labeled BLACK, covers about 
half of the genome, it is low in activation-associated histone modifications, 
and corresponds mostly to repressive chromatin. Genes in BLACK 
chromatin are mostly silent or expressed at very low levels in Kc167, and 
Filion et al. hypothesized that they were likely to be under developmental 
control. We have indeed found that 59% of the fly developmentally 
regulated genes occurred in BLACK chromatin—compared to 28% of all 
genes in Drosophila overall. In contrast, only 4% of developmentally stable 
genes are in BLACK chromatin (Fig. 7d).  
 
These results suggest that developmentally regulated genes are 
located in repressive chromatin domains, and that lack of histone 
modifications is not a transient genome property dependent on a cell type 
since it is observed both in developmental tissues and in cell lines.   
 
 
 
Strong chromatin marking in stably expressed genes is 
associated to tighter regulation of alternative splicing 
Beyond its role in primary RNA production, chromatin structure has 
also been recently implicated in subsequent steps of RNA processing. A 
number of studies have uncovered a relationship between nucleosome 
occupancy and exon-intron structure28, 29 and between specific histone 
modifications and alternative splicing30-32. We specifically investigated 
whether strongly positioned nucleosomes directly associate with exon 
inclusion. To isolate the effects of nucleosome occupancy on exon 
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inclusion from those of gene expression we computed the inclusion level 
of individual fly internal exons in WID and EID in a manner that is 
independent from overall gene expression (Methods). Then, within each 
tissue we selected highly included exons (inclusion level greater than 0.9) 
and lowly included exons (inclusion level lower than 0.1, Supplementary 
Tables 1, 9 and 10). Occupancy profiles at the exons’ acceptor site 
indicate that in both WID and EID, highly included exons are characterized 
by higher H3 occupancy when compared to lowly included ones (Fig. 8a, b), 
as it has been previously reported in mammals29. To characterize the 
relationship between nucleosome occupancy and exon inclusion we 
computed the correlation between these two variables on a running 250bp 
window centered at each nucleotide within the region -1,000 to +1,000 
from the acceptor site (Methods, Fig. 8c, d). The behavior of the 
correlation between H3 and exon inclusion is very similar for EID and WID: 
it significantly peaks very close to the acceptor site and essentially 
vanishes beyond 500 nucleotides from the acceptor site. This shows that 
the association of nucleosomes and exon inclusion is local, consistent 
across tissues and not negligible. 
 
We speculated, thus, that strong chromatin marking might not be 
only associated to more stable RNA production, but also to a tighter 
regulation of alternative splicing. To measure alternative splicing 
complexity, we computed the Shannon’s entropy on the relative 
abundance of a gene’s alternative splicing isoforms (Methods). The 
splicing entropy grows with the number of isoforms and with the evenness 
of their relative abundances. The entropy is zero when there is only one 
isoform being expressed (which would correspond to tight regulation of 
isoform expression), and it reaches its maximum when all isoforms are 
equally expressed (which would correspond to lack of splicing regulation 
and stochastic production of alternative splicing isoforms). Based on 
transcript quantifications produced by the modENCODE project for the fly, 
and computed by us for the worm (see Methods), we have calculated the 
splicing entropy of each gene at the developmental time point in which its 
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expression is at its maximum. As hypothesized, splicing entropy is lower 
for strongly marked stable genes than for unmarked developmentally 
regulated genes in both fly and worm for any number of annotated 
isoforms (Fig. 8e). Further supporting tighter regulation of splicing, we 
have also found that the major isoform captures a larger fraction of the 
total transcriptional output of the gene in stable than in regulated genes 
(Fig. 8f). 
 
Discussion 
Cell type specific transcriptional regulation is crucial to maintain cell 
identity throughout the lifetime of an organism, yet it must be flexible 
enough to allow for responses to endogenous and exogenous stimuli. This 
regulation is mediated by specific molecular factors (e.g. cell type specific 
transcription factors, and chromatin modifications), as well as by the 
topological organization of the genome. In particular, modifications 
occurring on DNA and on histone proteins regulate gene expression by 
establishing and maintaining specific chromatin states33, 34. It has become 
widely accepted that the association of certain modifications with 
transcriptional activation or repression is a general phenomenon. 
Nevertheless, expression of genes in the absence of chromatin marks has 
already been reported6, 7, 9. Here we found that transcriptional activation in 
the absence of most canonically active chromatin marks is actually a 
characteristic feature of genes that are regulated during development. We 
also found that strong chromatin marking appears to confer transcription 
stability. 
 
Analyses of tissue-specific gene expression data, as well as our 
targeted validation experiments, demonstrate that our observations do not 
arise from the expression of developmental-specific genes being lower or 
confined to small cell populations, from limited detection sensitivity, 
and/or from persistence in the cell of RNA molecules transcribed at some 
earlier standpoint. Our analyses further indicate that lack of chromatin 
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marking is not a transient genome state, but a constitutive property of 
these genes. Distinct dynamic properties of promoters differentially used 
during the zygotic genome activation have already been described in 
Drosophila, where pre-midblastula transition (pre-MBT) genes tend to have 
low levels of H3K4me3, even when pre-MBT genes continue to be 
transcribed during the MBT8. Of note, we found 25 out of 65 
developmentally regulated genes expressed at early embryonic 
stages among the 117 pre-MBT genes reported by Zeitlinger and 
colleagues8 in contrast to only one out of the  1,000 stable genes. 
 
 
We also found that a highly structured and strongly marked 
chromatin state leads to tightly controlled RNA production, not only at 
transcription but also at splicing level. We indeed observed higher 
stochasticity in the production of alternative splice forms in unmarked 
developmentally regulated genes than in marked stably expressed ones. 
Tighter regulation of splicing by chromatin marking is consistent with 
earlier observations35 of simultaneous enrichment in the expression of 
chromatin modifying enzymes and splicing factors in cell-enriched testis. It 
is also consistent with the higher levels of H3K36me3 found by de Almeida 
et al.30 in constitutive exons compared to alternative exons in mammalian 
genomes (a finding that we have also replicated in the fly genome, data 
not shown).  
 
Overall, our results lead us to hypothesize that the relative 
contribution of Transcription Factors and Histone Modifications defines 
two major broad transcriptional regulatory programs. In stable that are 
constitutively expressed, strong chromatin marking leads to 
transcriptional stability and tightly controlled RNA production. In these 
genes, regulation by Transcription Factors would play a comparatively 
smaller role. In contrast, developmentally regulated genes that need to be 
rapidly activated and de-activated are characterized by an unmarked 
chromatin state. In these genes, Transcription Factors binding to 
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chromatin would play the predominant regulatory role. It is unclear 
whether this model of transcriptional regulation can be generalized to 
other metazoans. While detailed transcriptional and epigenetic maps are 
being produced in an increasing number of cell lines and tissues (both 
healthy and diseased), developmental maps are still sparse in mammalian 
species. Exhaustive monitoring through a much larger variety of 
conditions, differentiation states and developmental stages is required to 
fully understand the layer of epigenetic regulation that mediates between 
genome sequence and RNA production. 
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Online Methods 
Drosophila strains 
The strains used were: Canton S as a wild- type and nub-GAL4/+; 
UAS-GFP/+. Flies were kept on standard media at 25ºC. 
 
Tissue disaggregation and cell sorting 
Wing imaginal discs (WID) from nub-GAL4/+; UAS-GFP/+ flies were 
dissected in PBS and incubated for 1h in a 10x trypsin solution (Sigma 
T4174) at room temperature in a rotating wheel. Cells were vigorously 
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pipetted and kept on ice in Schneider’s insect medium. To discard dead 
cells, DAPI was added to the sample at 1 mg/mL final concentration. Cells 
were sorted in a FACSAria (BD) with the 85 mm nozzle. We were able to 
recover around 2.5·106 GFP negative and 2·106 GFP positive cells from 400 
WIDs. An independent sorting experiment was done per each replicate, 
both for ChIPs and gene expression analyses. 
 
RNA extraction, retrotranscription and Real-Time PCR 
As starting material, 120 WID and 250 eye-antenna imaginal discs 
(EID) were used for RNASeq. For Pdm2 gene expression analysis, WIDs 
from 400 nub-GAL4/+; UAS-GFP/+ flies were disaggregated. RNA from 
sorted cells was extracted with ZR-RNA MicroPrep Kit from Zymo Research. 
For L3-specific genes expression, 5 third instar larvae were frozen and 
RNA was extracted with Quick-RNA MiniPrep Kit, from Zymo Research. 
Retrotranscriptions and qPCRs were performed as described previously11. 
For quantification of RNA amounts, standard curves of each pair of primers 
were performed and the efficiency of amplification was calculated. The Cts 
obtained from the qPCR were corrected according to the amplification 
efficiency of the primers. Primers used for Real-Time PCR are listed below. 
 
In situ hybridizations 
In situ hybridizations using digoxigenin labelled riboprobes were 
carried out according to standard protocols. The probe for Pdm2 in situ 
was PCR amplified using primers listed below and cloned into a pBSK+/- 
vector at EcoRI restriction site. Riboprobes were synthesized using T7 
polymerase. WID and EID were analyzed with a Leica DMLB microscope. 
 
Chromatin immunoprecipitation 
Third instar larva WID or EID isolated from Canton S flies were fixed, 
pooled in 700 mL and processed as described11. From 300 to 600 imaginal 
discs were used in these experiments. Trypsin treated cells from GFP 
transgenic flies were fixed after sorting for 10 minutes at room 
temperature and sonicated in a Diagenode Bioruptor for 15 minutes at 
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high power in lysis buffer (1% SDS, 10 mM Tris HCl ph 8.0 and 2mM EDTA). 
Immunoprecipitations were performed in RIPA buffer. For L3 ChIPs and 
Imaginal Discs ChIPSeq experiments we used 1 mg of the corresponding 
antibody. For ChIPs in sorted cells we used 0.45 mg of anti-H3K4me3, 0.3 
mg of anti-H3K36me3, 0.33 mg of anti-H3K27ac and 1 mg of anti-
H3K27me3. For L3 time-specific ChIPs, 5 Canton S wall-wandering third 
instar larvae were disrupted and fixed 10 minutes at room temperature. 
Fixed larvae were sonicated in a Diagenode Bioruptor for 15 minutes at 
high power in lysis buffer. Immunocomplexes were recovered with 
Invitrogen ProteinA magnetic beads for 2h. The beads were washed three 
times in RIPA or IP buffer for 10 minutes, once in LiCl buffer and twice in 
TE11. 
The primers used for Real-Time PCR are listed below. The antibodies 
used for ChIP were: H3 (Abcam/ab1791); H3K4me3 (Abcam/ab8580) 
(Millipore-Upstate/07-473), H3K9ac (Abcam/ab4441), H3K36me3 
(Abcam/ab9050), H3K4me1 (Diagenode/CS-037-100) and H3K27ac 
(Abcam/ab4729).. 
 
Nascent RNA 
For Nascent RNA assays, 400 WIDs nub-GAL4/+; UAS-GFP/+ were 
dissected and disaggregated as described above. Click-IT® Nascent RNA 
Capture Kit from Molecular Probes (cat. number C10635) was used 
according to the manufacturer’s instructions. Briefly, disaggregated cells 
were incubated with 0.5 mM 5-ethynil uridine (EU) in Schneider’s Insect 
Medium for 1 h at room temperature. Total RNA was extracted and 
biontinylated with 0.25 mM biotin-azide for 30 minutes at room 
temperature. Biotinylated RNA was precipitated over night at -80ºC and 
purified with Streptavidin conjugated beads for 30 minutes at room 
temperature. Nascent RNA was eluted in 0.1 % SDS 5 minutes at 99ºC and 
retrotranscription was carried out as described above. Four biological 
replicates were performed. Primers used for Real-Time PCR are listed 
below. 
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Primers for cloning and qPCR 
 
 
Solexa/Illumina sequencing 
Solexa/Illumina sequencing was carried out at the Ultrasequencing 
Unit of the Centre for Genomic Regulation (CRG, Barcelona, Spain. All 
protocols for Solexa/Illumina ChIPSeq and for RNASeq analysis were 
carried out following the manufacturer’s protocol. For ChIPSeq, 10 ng of 
each sample were used and fragments between 300 and 350 bp were size 
selected before sequencing. For RNASeq, 5 mg of total RNA were used to 
sequence. 
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Drosophila melanogaster genome and annotation 
We used the FlyBase13 annotation release 5.12 for the genome 
version dm3. 
 
 
RNASeq and ChIPSeq read mapping 
Reads of 36 and 40 bp obtained from single-end RNASeq and 
ChIPSeq sequencing from WID and EID-cells were aligned using GEM36 
allowing up to two mismatches to the D. melanogaster genome (version 
dm3) and, for RNA, to all possible junctions of 5’-3’-ordered exon pairs 
occurring within the same annotated gene. ChIPSeq and RNASeq raw data 
and profiles of read counts were deposited in the NCBI-GEO repository 
under the accession number GSE56551.  
 
Gene and transcript expression analysis 
Reads mapping uniquely to the genome were used to quantify genes 
and transcripts separately in each tissue using the FluxCapacitor37. 
Expression levels are given in Reads Per Kilobase per Million mapped reads 
(RPKM).  Linear regression analysis between log transformed WID and EID 
RPKMs gave a highly significant slope and intercept. Thus, we identified 
628 genes at least one unit above the linear regression line (differentially 
expressed genes in EID) and 184 genes at least one unit below 
(differentially expressed genes in WID). To build our collection of regulated 
tissue-specific genes from each differentially expressed gene set, we 
required cv >= 1.2 and at least 1.5 RPKMs in one tissue and less than 0.1 
RPKM in the other one (55 EID-specific genes and 10 WID-specific 
genes, respectively, resulted from this criterion). Finally, those genes with 
cv < 1.2 that are expressed in both tissues (> 2.3 RPKMs) with a difference 
in expression of less than 20% were selected as stable expressed in the 
two tissues (284 genes) and the genes whose expression in both tissues is 
0 RPKMs were considered to be silent (30 genes). 
 
 
Results – Part I 
 
 54 
ChIPSeq analyses 
ChIPSeq reads for H3, H3K4me3, H3K9ac, H3K36me3, H3K4me1 and 
H3K27ac were extended to the full average fragment length in the 
corresponding experiment. For each position in the genome the number of 
extended ChIPSeq reads overlapping this position was recorded. Each 
sample was normalized by the total number of sequenced reads and the 
average fragment length. The genome-wide correlation between WID and 
EID samples was computed using the UCSC Table browser on windows of 
1,000 nucleotides38. To compute the correlation between ChIPSeq samples 
and RNASeq expression data, we assigned to each gene the highest peak 
of the corresponding ChIP signal within the body gene and correlate this 
value to the expression of the gene. To produce the graphical distribution 
of reads for each sample around a particular site (Transcription Start Sites, 
TSS, polyAdenylation Sites, pAS and splice Acceptor Sites, AS), we 
calculated the weighted number of reads on each position from -500 bp to 
+500bp of each TSS, pA and AS, according to FlyBase. To graphically 
represent an idealized gene, we normalized the location of the reads 
within the gene using a window of 100 units, and calculated the mean at 
each point. We extended this representation 500 bps upstream and 
downstream of the gene. To compare WID and EID samples, we calculated 
the weighted number of reads on each position in the normalized ChIPSeq 
profiles. 
 
modENCODE analyses 
Stable and developmentally regulated genes in D. melanogaster 
To define the transcriptional stability of genes, we calculated the 
coefficient of variation of gene expression, as reported by the modENCODE 
consortium10, for each protein-coding gene that has detectable expression 
in 12 selected time points (Supplementary Fig. 1a). From the full ranking 
of 13,635 genes, we defined the bottom 1,000 genes with lowest variation 
of expression during development as stable, and the top 1,000 genes with 
highest variation as developmentally regulated genes. In addition, at each 
time point we selected the same number of silent genes than 
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developmentally regulated genes expressed at that time point, for a total 
of 1,000 silent genes.  For these genes, we measured the strength of the 
highest peak (measured as the log of the number of reads reported by 
modENCODE) within the gene body at the time point in which its 
expression is maximum for H3K4me3, H3K9ac, H3K4me1, H3K27ac, and 
the average signal within the gene body for H3K27me3 and H3K9me3 
modENCODE ChIPSeq profiles (NCBI GEO accession: GSE16013). Due to 
data issues with ChIPSeq for three samples: H3K9ac (Adult male) and 
H3K9me3 (L3 and Adult male), we used ChIP-chip data in these cases 
instead. The Wilcoxon test (two-sided) was used to evaluate the statistical 
significance of the difference between ChIP values for stable and 
developmentally regulated genes on each sample. To build the subsets of 
low, medium and high regulated genes, we ranked the top 1,000 regulated 
genes by their expression (in the time point of maximum expression) and 
we classified them into three groups of the same number of genes. 
 
Stable and developmentally regulated genes in C. elegans 
We estimated H3K4me3 and H3K36me3 levels in 7 developmental 
stages (Early Embryo, Late Embryo, Larvae L1, L2, L3, L4 and Young Adult) 
from array signal files in Gerstein et al24. To define developmentally stable 
and regulated genes, we also used the same procedure as in fly. To obtain 
gene and transcript quantifications, we mapped the RNASeq reads from 
modENCODE C. elegans24 to the Wbcel215.68 version of the genome using 
GEM36, and used the FluxCapacitor37 to produce the quantifications.  
 
 
 
L3-specific genes analysis 
To compare the expression and histone modification marking levels 
in regulated broadly expressed and stable tissue-specific genes we used 
anatomy RNASeq data from modENCODE consortium available in Flybase13. 
We used the gene sets previously defined for modENCODE analysis to 
create new subgroups of genes:  
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• Stable: the 1,000 genes with the lowest coefficient of variation of 
gene expression across modENCODE time points  
• Silent: genes identified as silent in L3 stage (RPKM=0) 
• Regulated broadly expressed at L3: developmentally regulated genes 
that are detected in L3 whole body data, and that are furthermore 
expressed with at least 1 RPKM in each of the 6 tissues with L3 tissue-
RNASeq available 
• Stable tissue-specific at L3: from the set of extended stably 
expressed genes (P1 in Supplementary Fig 4) we selected the genes that, 
using L3 tissue-RNASeq, are detected as expressed with at least 10 RPKM 
in 1 of the tissues and not higher than 1 in all the other remaining tissues. 
We identified 26 carcass-specific genes, 8 central nervous system-specific 
genes, 36 digestive-specific genes, 21 fat body-specific genes, 36 imaginal 
disc-specific genes and 4 salivary glands-specific genes. 
The expression and histone modification levels were calculated 
using L3 data from modENCODE following the methodology of the 
previous analysis. 
 
Promoter analyses 
To measure the conservation of the promoters of regulated and 
stable genes across 12 Drosophilids, we computed the average of the 
UCSC PhastCons multiz15way track38 along the promoter sequences of 
each gene set (promoter length: 200 bp). To characterize the promoters of 
regulated and stable genes, we used the MatScan program39 with the full 
collection of 827 predictive matrices available in Jaspar and Transfac40, 41. 
From each initial pool of predictions, we removed those binding sites 
within genome regions in the UCSC genome browser that presented on 
average a probability lower than 0.95 to be conserved across the 12 flies 
PhastCons multiz15way alignments19. The Wilcoxon test (one-sided) was 
used to evaluate the statistical significance of the difference for stable and 
developmentally regulated gene sets on each comparison (PhastCons 
scores and number of conserved sites). For the identification of 
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focused/dispersed initiation sites8, 22, we searched for putative binding 
sites of TBP, GAGA, Zelda and DRE in the promoter sequence of the top 
1,000 stable and the top 1,000 regulated genes (promoter length: 100 bp). 
We selected TBP as a marker of focused initiation and DRE as a 
representative of dispersed initiation. GAGA and Zelda are not 
characteristic of a particular transcriptional model. The weight matrices for 
TBP and GAGA are from Jaspar40 and for Zelda and DRE are from Fly Factor 
Survey42.  
We performed principal components analysis (PCA) based on the 
ChIPSeq levels of 20 Transcription Factors in Embryos at 0-12h in the 
promoter regions of genes with expression above 10 as measured by 
tilling arrays at this time point6. 
 
Splicing entropy  
For each gene, we computed the Shannon’s entropy (or diversity 
index) based on the relative frequencies of the gene’s annotated isoforms 
in a given cell line. Let g be a gene with n annotated isoforms with relative 
frequencies p1, …,pn, in a given condition, the entropy of g, H(g), is 
computed as 
 
H(g) growths with the number of annotated isoforms and with the 
evenness of their frequencies. H(g) is zero when there is only one 
expressed isoform, and it is maximum when all isoforms are equally 
expressed. The boxplots in Fig. 8c, d display the distribution of H(g), 
separately for genes with different number of isoforms. 
 
  
H (g) = − pi
i=1
n
∑ ln pi
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Figure captions 
Figure 1: Distribution of histone modifications during fly 
development. a, Expression of stable, regulated, and silent genes during 
fly development at the time point of maximum expression for each gene. 
Gene expression was computed as FPKMs by the modENCODE consortium. 
b, Levels of H3K4me3, H3K9ac, H3K4me1 and H3K27ac at the time point 
of maximum expression during D. melanogaster development. These 
values represent the maximum height of the ChIPSeq peak within the body 
of the gene. P-values were computed using the Wilcoxon text (two-sided). c, 
Profiles of H3K4me3 during the twelve fly developmental time points in 
CG8636, a gene stably expressed during fly development, and CG16733, a 
pupa-specific gene. The expression (measured as FPKMs) along these 
points for these two genes is given on the left. d, Levels of H3K27me3 and 
H3K9me3 at the time point of maximum expression, computed as the 
average height of the ChIPSeq signal within the body of the gene, in stable, 
regulated and silent genes. 
 
Figure 2: Distribution of histone modifications during worm 
development. a, Expression of stable, regulated and silent genes during 
worm development at the time point of maximum expression for each 
gene. b, Levels of H3K4me3 and H3K36me3 at the time point of maximum 
expression during worm development. These values represent the 
maximum height of the ChIP-chip peak within the body of the gene. P-
values were computed using Wilcoxon text (two-sided). 
 
Figure 3: Gene expression and histone modifications in regulated 
broadly expressed and stable tissue-specific genes at third instar 
larvae. a, Diagrams of developmentally regulated genes broadly expressed 
across multiple tissues at third instar-larvae L3 (left panel), and stable 
genes expressed in only one tissue at L3 (right panel). b, Gene expression 
levels at L3 measured by whole organism RNASeq (left panel). The number 
of genes in each category is given under the boxplots. Validation by qPCR 
of the expression at L3 of regulated broadly expressed genes compared to 
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a stable gene (Bmcp) and a silent gene (CG5367) (right panel). Error bars 
represent the Standard Error of the Mean (SEM) from three independent 
replicates. c, Levels of H3K4me3, H3K9ac, H3K4me1 and H3K27ac on 
whole L3 individuals. The seven regulated genes broadly expressed at L3 
are depicted as red dots within the boxplots. P-values were computed 
using the Wilcoxon test (two-sided). d, Validation by individual ChIPs and 
qPCR of H3K4me3 and H3K9ac in regulated genes broadly expressed at L3. 
H3K4me3 and H3K9ac ChIPs are represented as enrichment of the marks 
over the silent gene (CG5367). Error bars represent the SEM from three 
independent replicates. 
 
Figure 4: Profiles of H3 and histone modifications in Wing (WID) 
and Eye-antenna (EID) imaginal discs. a, Profiles on stable and silent 
genes in WID and in EID. b, Profiles on regulated WID-specific genes in WID 
and EID. c, Profiles on regulated EID-specific genes in WID and EID.  
 
Figure 5: Profiles of RNA expression, H3 and histone 
modifications in Wing (WID) and Eye-antenna (EID) imaginal discs. Noc 
is a gene stably expressed in WID and EID; CG4382 a WID-specific and 
CG14516, an EID-specific gene. Levels of gene expression (as RPKMs) are 
depicted at the bottom of the panels. Screenshots have been obtained 
through the UCSC Genome Browser38.  
 
Figure 6: Active transcription of Pdm2 without chromatin 
modifications. a, Expression of Pdm2 in WID (left panel) and EID (middle 
panel) labeled with a Pdm2-specific probe. The gene is only expressed in 
the wing pouch of the WID, highlighted in green. b, Expression of Pdm2 in 
sorted cells analyzed by qPCR. Error bars represent the SEM from three 
biological replicates. c, ChIP analysis of H3K4me3, H3K36me3 and of 
negative controls without antibody on sorted cells. ChIPs are represented 
as enrichment of the marks over a silent gene non-marked with H3K4me3 
and H3K36me3 (CG10013). Error bars represent the SEM from at least 
three biological replicates. P-values were computed using the t-test (two-
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sided). d, Newly transcribed RNA of GFP-sorted cells. Nascent RNA is 
normalized by the control gene crm. Error bars represent the SEM of four 
biological replicates. 
 
Figure 7: Promoter architecture in stable and developmentally 
regulated genes. a, Conservation of core promoter sequence. Upper 
panel: distribution of PhastCons scores derived from 12 Drosophila 
species in the promoter sequence (defined as 200 bp upstream of the TSS) 
of stable and regulated genes. Lower panel: conservation of transcription 
factor binding motifs. We identified the predicted binding motifs for 
Transcription Factors that have a PhastCons score greater than 0.95 in the 
promoter sequence of stable and variable genes. Boxplots show the 
distribution of the number of conserved motifs only for promoters that 
contain at least one prediction. P values were computed using Wilcoxon 
test (one-sided). b, Percentage of the promoters in stable and regulated 
genes that contain binding sites for TBP, GAGA, Zelda and DRE. c, Principal 
component analysis (PCA) of genes expressed in the Drosophila embryo 
between 0 and 12h, based on the ChIP-chip binding profiles at their 
promoters of 20 Transcription factors. d, Stable and regulated genes in 
chromatin domains segmented according to Filion et al.27. The BLACK 
corresponds mostly to repressive chromatin. YELLOW and RED chromatin 
contain proteins and histone modifications typical of transcriptionally 
active regions. GREEN and BLUE chromatin correspond to two types of 
repressive chromatin: heterochromatin including heterochromatin protein 
1 (HP1) (GREEN) and Polycomb group (PcG)-associated chromatin (BLUE).  
 
Figure 8: Chromatin structure and splicing. a-b, H3 on highly (red) and 
lowly (blue) included exons in WID (a) and EID (b). c-d, Correlation between 
exon inclusion and H3 across exon acceptor sites in WID (c) and EID (d). e, 
Distribution of Shannon’s Entropy in stable and regulated genes. 
Shannon‘s entropy is computed at the time point during development in 
which gene expression is the maximum. The number of genes of each 
category appears below the X-axis in grey. f, Distribution of the relative 
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usage of the major isoform for genes with different number of isoforms. 
The Y-axis is the fraction of the total transcriptional output of the gene 
that is captured by the most abundant isoform.  
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Abstract 
Background 
Pre-mRNA splicing occurs, in large part, co-transcriptionally and 
both nucleosome density and histone modifications have been proposed 
to play a role in splice site recognition and regulation. The extent of these 
interplay, and the mechanisms underlying it, remain however, poorly 
understood.  
Results 
We used transcriptomic and epigenomic data generated by the 
ENCODE project to investigate the association between chromatin 
structure and alternative splicing. We did found a strong and significant 
positive association between H3K9ac, H3K27ac, H3K4me3 and inclusion in 
a small, but well defined class of exons (about 4% of all regulated exons). 
These exons are systematically maintained at comparatively low levels of 
inclusion across cell types, but their inclusion is significantly enhanced 
when in physical proximity (either in linear or in the 3D space) of active 
promoters. 
Conclusion 
Histone modifications and other chromatin features that activate 
transcription could be co-opted to participate in the regulation of the 
splicing of exons that are in the physical proximity of promoter regions. 
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Introduction 
 
Alternative pre-mRNA splicing is assumed to expand the diversity of 
mRNAs encoded in the genome. The prevalence of alternative splicing 
increases from invertebrates to vertebrates [1] and is particularly high in 
the immune and nervous systems, where high diversity of molecular 
repertoires is necessary for cell identity [2]. Whether an alternative exon is 
included or excluded in a mature RNA is considered a matter of 
combinatorial control, involving splice sites, additional binding sites and 
the factors that recognize them [3]. Recent evidence suggests that 
chromatin organization and transcriptional dynamics may also contribute 
to this control. First, splicing can occur co-transcriptionally [4, 5], and this 
has been demonstrated to be widespread in yeast [6], fruit fly [7], and 
human [8, 9]. Second, some splicing factors are known to interact with 
modified histone tails, and intragenic histone modifications have been 
shown to be involved in alternative splicing decisions on individual genes 
[10]. Third, RNA Polymerase II elongation dynamics is known to influence 
exon inclusion [11, 12], which was shown to be modulated by CTCF 
binding [13]. Lastly, a number of independent studies demonstrated that 
nucleosome density correlates with exon-intron architecture genome-wide 
[9, 14-19], and specifically with exon inclusion levels [20, 21].  
 While links between chromatin and splicing have thus been 
established, attempts to incorporate chromatin information on quantitative 
models predictive of cell type specific exon inclusion levels have met so far 
with moderate success [22], and the extent to which cell-type specific 
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chromatin organization contributes to cell-type specific splicing patterns 
remain largely unknown.  
Here to investigate the relationship between chromatin and splicing, 
we analyzed transcriptome and epigenome data generated in a number of 
human cell lines within the ENCODE project [23, 24]. First, we used 
RNASeq data to identify exons that are differentially included between cell 
lines. We found that a relatively small fraction of human exons (about 3% 
of all internal exons) exhibit regulated inclusion across human cell lines. 
These regulated exons are maintained at intermediate inclusion levels 
compared to all exons. Second, we used ChIPSeq data to investigate the 
association between the inclusion of regulated exons and histone 
modifications. Our results strongly suggest that there is little or no direct 
association between histone modfications and the inclusion levels of the 
majority of these exons.. We identified, however, a small set of regulated 
exons (about 4% of all differentialy included exons) in which cell type 
specific inclusion levels do appear to be directly associated to levels of 
canonically activating histone modifications. In contrast to most exons, the 
inclusion of these exons is maintained at remarkabe low levels across a 
large variety of cell types and tissues. In addition of being enriched in 
histone modifications, these exons have other characteristics typical of 
promoter regions, but they do not correspond to sites of transcription 
initiation. However, they tend to lay closer to transcription initiation sites, 
and through chromatin looping they tend to interact with promoter 
regions.  
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Our observations are consistent with a role for promoter regions and 
for promoter-characteristic epigenetic signatures in the regulation of the 
alternative splicing of a well-defined set of exons, possibly involving the 
opening of chromatin and folding of chromatin loops that bring together 
regulated exons and promoters into close spatial distance. Histone 
modifications and other features that activate transcription could then be 
co-opted in these cases to participate also in the regulation of exon 
inclusion. 
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Results
 
 
R1. Alternatively included exons in pair-wise cell type 
comparisons 
We used nuclear polyA+ RNASeq samples from five Tier 1 human cell 
lines from the ENCODE project (K562, Gm12878, Hepg2, Huvec, Helas3) 
[25] to identify differentially included internal exons in pair-wise 
comparisons of cell lines.  We used a method similar to that published by 
Wang and coworkers [26] (Figure 1a, Methods, Figure S1). Nuclear polyA+ 
RNA was selected, since, in contrast to other RNA fractions, in this fraction 
splicing has been essentially completed [9], but it is unlikely to have 
undergone nonsense mediated decay (NMD), and thus, it reflects more 
precisely the direct outcome of splicing. 
We selected 73,329 internal exons with canonical splice junctions 
that lay at least 600bp away from the closely annotated Transcription Start 
Site (TSS) and Transcription Termination Site (TTS), and for which there 
were enough RNASeq reads to compute differential inclusion in at least 
one pairwise cell comparison  (see Methods). We used the one-side Fisher 
test on the number of exclusion and inclusion reads to identify 
differentially included exons between each cell-pair (see Methods). Exons 
with significant inclusion level changes were called more/less included 
exons depending in the direction of the change (Figure 1a). Figure 1b-g 
shows the results of the comparison of Gm12878 and K562. We identified 
1688 exons regulated between these two cell lines (1066 more included in 
Gm12878 and 622 more included in K562, p-value <0.05, Figure 1b). 
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These differentially included exons possess known properties of 
alternative exons, as previously described in the literature [27, 28]: 1) they 
have weaker splice sites compared to exons not differentially included 
(Figure 1c), 2) they tend to be shorter (Figure 1d) and, 3) when coding, 
their length is more often divisible by three (Figure 1e). Moreover, 4) we 
did not find significant differences in the expression levels of the genes 
hosting differentially included exons between the two cell lines compared 
(Figure 1f). In order to independently validate our alternative exon calling 
method, we selected a total of 15 of these exons (Figure 1g). Using exon-
junction oligonucleotides (Table S1), we quantified by qPCR the ratio of 
inclusion/skipping isoform in Gm12878 compared to K562. This method 
of quantification provides an assessment of the differences in the relative 
inclusion of the exons regardless of possible differences in gene 
expression between the cell lines compared. We validated 12 out of the 15 
selected cases (Figure 1g), corresponding to a validation rate of 80%.  
We assessed whether conditions 1-4 above (Figure 1c-f) where 
satisfied in each of the ten pairwise comparisons between the five cell 
lines considered here, and we kept only the seven comparison satisfying 
all of them (Table S2). Furthermore, we retained only exons with minimum 
absolute change of 0.1 or 2-fold in the inclusion levels between the two 
cell lines. In total, we obtained 1849 more included and 2483 less 
included exon comparisons in the seven cell-pairs employed. The terms 
“more included exons” and “less included exons” are arbitrary, since they 
depend on the direction of the comparison. We preferred to keep them 
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separate to allow for better visualization and validation of the results 
presented (see below).  
Because the same exon can appear in different pairwise 
comparisons, when pooled together, the two sets correspond to 2081 
unique exons that showed regulated inclusion levels across the human 
ENCODE cell lines. This corresponds to about 3% of all exons initially 
considered. Exons with regulated inclusion exhibit in general weak 
inclusion changes across human cell lines (Figure 2a). The median exon 
inclusion range (that is, the differences between the maximum and 
minimum inclusion observed) is 0.20. For more than 90% of the exons, the 
change is less than 0.5. Moreover, they show generally intermediate exon 
inclusion levels when compared with the inclusion levels of non-regulated 
exons (Figure 2b).   
Because gene expression levels are linked to chromatin organization 
[29] and can also influence splicing [3], we excluded exons from genes 
showing large (more than 10 fold) expression differences between cell 
lines. In addition, in our analysis, we used only one exon per gene, the one 
with the lowest p-value. In total, we obtained 1684 more included and 
2198 less included exon comparisons in the seven cell-pairs employed 
corresponding to 1921 unique exons (Table S3, Additional file 1 and 2). 
 
R2. Co-occurrence of differences in histone modifications with 
alternative exon inclusion  
For each differentially included exon in each pairwise cell 
comparison, we computed differential signal for nine histone marks, the 
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insulator protein CTCF and input DNA [24, 30, 31]. We defined the 
“differential signal” for each chromatin feature as the difference of the 
average normalized signal over the exon in the second cell type (e.g. 
Gm12878 for the comparison K562 vs. Gm12878) and the average signal 
over the exon in the first one (e.g. K562 for the same comparison, see 
Methods). We pooled the differential exonic signal across all exons and all 
comparisons together to produce a single composite comparison for each 
monitored variable separately for “more included” and “less included” 
exons. By using differential signals on the same genomic interval, we 
eliminated possible biases due to intrinsic genomic features such as GC 
content. 
Our analysis revealed enrichment of CTCF, H3K9ac, H3K27ac and 
H3K4me3 levels in more included exons (p-value< 0.01; Wilcoxon signed-
rank test with Bonferroni correction) (Figure 3a). We also observed a 
negative association with the control signal, which consists of cross-linked 
and sonicated DNA. This may represent a measure of chromatin 
compaction, and may reflect an association between open chromatin and 
higher levels of exon inclusion. Importantly, the association observed 
between exon inclusion and input DNA is in the opposite direction than 
that observed for rest of the chromatin features, indicating that we are 
likely underestimating the strength of the associations. To validate these 
results, we performed ChIP-qPCR using H3K9ac antibodies and primers 
specific for the target exons (and a constitutive exon of the same gene as 
a control) in K562 and Gm12878 cells. In all four alternative exons 
investigated, a clear difference in H3K9ac signal between the two cell lines 
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was detected, positively correlating with differential exon usage. In 
contrast, constitutive exons on the same genes showed, in general, 
smaller (sometimes even opposite) differences and higher variability 
among replicates (Figure 3b). 
To assess whether the differential enrichment in histone 
modifications was local and specific of the regulated exons, or rather 
affected more extensive regions of the gene, we analyzed the distribution 
of epigenetic marks in the closest upstream and downstream exons that 
our method did not identify as differentially included (Methods). This 
defines a “not regulated -regulated - not regulated” exon triplet. 
Differential chromatin profiles were calculated within 800bp windows from 
the center of the exons. The results showed that the enrichment in 
chromatin signals does not extend to the flanking exons and it is, 
therefore, specific of the differentially included exons (Figures 3c-f). This 
confirms a significant positive association between exon inclusion and 
local levels of H3K9ac, H3K27ac, H3K4me3 and CTCF binding.  
 
R3. Promoter-like histone marks and exon inclusion 
 
While the results above do indicate a significant association between 
a number of histone modifications and exon inclusion, the effect is 
certainly weak. This could reflect a general, but weak effect of histone 
modification on most differentially included exons, or alternatively, a 
strong effect only on a subset of them. To investigate the two alternatives, 
we performed k-means clustering on the sets of more and less included 
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exons, based on the levels of the five chromatin features that we found 
significantly associated with differential exon inclusion. After k-means 
optimization, the data was partitioned in four clusters of different signal 
profiles and each exon was assigned to the cluster with the nearest mean 
(Figure 4). As expected “more included” and “less included” exons 
generated similar but mirrored clusters. 
While the majority of differentially included exons do not show 
differences in the levels of the monitored histone modifications, a subset 
of exon comparisons (59 “more included” and 41 “less included”, 
corresponding to 70 unique exons) exhibits large differential levels of 
H3K9ac, H3K27ac and H3K4me3 associated with differential exon 
inclusion (Figure 4, Additional file 3). Thus, while the inclusion of the 
majority of exons does not appear to be directly associated to levels of 
chromatin marks, some histone modifications are strongly correlated with 
the regulation of the inclusion of a subset of exons (about 4% of all 
differentially included exons). Principal Component Analysis (PCA) 
confirmed these results (Figure S3).  
To further validate these findings, we compared K562 and NHEK, an 
ENCODE Tier 2 cell line that had not been previously used in our analysis. 
Out of the 70 exons above, 22 are differentially included between these 
two cell lines. In 17 of them (77%), the direction of the differential 
inclusion is consistent with the direction of the differential levels of 
H3K9ac, H3K27ac and H3K4me3 (Figure S3), while only in three cases 
(14%) exon inclusion and histone modification levels change in opposite 
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directions. In the remaining two cases, no change in histone modification 
levels could be detected. 
These exons, which inclusion levels appear to be associated with 
levels of H3K9ac, H3K27ac and H3K4me3, will be referred to as “promoter-
like” exons since these histone modifications are known signatures of 
promoters. To further characterize them, we merged the two sets of 
“promoter-like exons” in one single group, retaining the association with 
the pair of cell lines where they were identified as differentially included. 
From now on, these cell lines will be referred to as “C-higher” (the cell line 
in which the exons are more included) and “C-lower” (the cell line in which 
they are less included). 
Compared to the rest of regulated exons, “promoter-like” exons are 
included at particularly low levels (median inclusion level of 0.32 and 0.07 
in “C-higher” and “C-lower” cell lines, respectively, compared with 0.54 and 
0.23 of the non promoter-like regulated exons (Figure 5a). To assess 
whether low inclusion levels are constitutive of “promoter-like” exons, or a 
consequence of our measurements restricted to human cell lines, we used 
1,500 RNASeq samples from the GTEx project [32], to estimate exon 
inclusion levels of the set of regulated exons in human tissues. We found 
that also in human tissues, “promoter-like” exons exhibit significantly 
lower levels of inclusion that regulated “non promoter-like” exons (Fig S4). 
 “Promoter-like” exons are characterized by additional promoter-
associated features when compared to the rest of regulated exons. First, 
they are enriched in binding sites, both when considering sequence motifs 
(Table S5 and S6), and accumulation of Transcription Factor (TF) ChIPSeq 
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reads. Indeed, we found that 15 out of the 32 TF analyzed have 
significantly more accumulation of reads in C-higher than in C-lower cell 
lines, while none displays the opposite trend (Figure 5b and S5). Among 
the enriched transcription factors is Brg1, which together with Brm is one 
of the two ATPases of the chromatin remodeling complex SWI/SNF, and it 
has been shown to interact with the splicing machinery [33]  (Figure S5b). 
Second, they are enriched in DNase I hypersensitive sites (DHS) in C-higher 
cell lines (Figure 5c). The difference in DHS signal is present in the 
regulated exon but not in the surrounding non-regulated ones. DHS are 
indicative of open, more accessible chromatin; they usually mark cis-
regulatory elements, including promoter and enhancer sequences. We also 
found a weaker enrichment in the set of all regulated exons (Figure S6). 
Third, under conditions of higher inclusion, they also show a clear 
enrichment of RNA Polymerase II signal (Figure 5d).  
All these promoter associated features in “promoter-like exons” 
could suggest that these exons actually overlap un-annotated TSS—in 
which case, elevated levels of H3K9ac, H3K27ac and H3K4me3 could 
simply reflect the action of transcription, and be unrelated to exon 
inclusion. To rule out this possibility, we analyzed the number of CAGE 
tags (sequence tags that target specifically the 5’ end of transcripts [34] 
mapping to “promoter-like” exons, and find it marginal when compared to 
the level in annotated TSS (Figure 5e).  We also found no significant 
difference in the distribution of upstream and downstream junction 
inclusion reads (RNASeq reads that connect two neighboring exons), 
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further confirming that “promoter-like exons” are indeed “bona fide” exons, 
and do not represent, as a bulk, un-annotated TSSs (Figure S7).  
 
R4. Proximity to the promoter and exon inclusion 
In spite of not being promoters themselves, “Promoter-like” exons 
are significantly closer to the annotated TSSs when compared to the rest of 
differentially included exons (Figure 6a), and actually most of them are 
second exons of the transcript, with their upstream exon beginning at the 
TSS itself. This explains the enrichment of DHS and Pol II signals in the 
non-regulated exons upstream of “promoter-like exons” (Figures 5c,d)—
albeit these enrichments are not significantly different between C-higher 
and C-lower cell lines, in contrast to the enrichments in the “promoter-like” 
exons. Moreover, analyzing clusters of CAGE tags, which are assumed to 
indicate annotated or un-annotated TSS, we observed alternative TSS usage 
for “promoter-like” exons in C-higher and C-lower conditions (Figure 6b). 
We found that in 45 of the 100 “promoter-like” exon comparisons, the 
active TSS closest to the exon is closer in the C-higher cell line than in the 
C-lower cell line, while in only 6 exon comparisons is the other way around 
(Figure 6b,c). For eight exon comparisons we found CAGE clusters within 
the exonic region, suggesting that these exons could indeed correspond 
to new, un-annotated TSSs. This could explain the significant CAGE 
enrichment occupancy in “promoter-like” exons when comparing C-higher 
and C-lower cell lines (Figure 5e). Figure 6d shows an example of an exon 
with higher inclusion level in Hela than in Gm1278 and with a closer active 
TSS being used only in the cell line of higher inclusion.
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These results suggest that regulated enrichment of histone 
modifications and other promoter-associated features in “promoter-like” 
exons could be the consequence of the physical proximity between these 
exons and real promoters. Transcription activating histone modifications 
would thus be “co-opted” to participate also in the regulation of inclusion 
of “promoter-like” exons. To further test this hypothesis, we analyzed 
genome-wide Chromatin Interaction Analysis with Paired-End-Tag 
sequencing (ChIA-PET) data that has been used to map long-range 
chromatin interactions associated with RNA polymerase II un-
phosphorylated ser2, found in the transcription pre-initiation complex, a 
characteristic mark of the gene promoters [35]. Indeed, it has been 
recently shown that some internal exons loop and physically interact with 
promoter and enhancers, and for this reason display “promoter-like” or 
“enhancer-like” chromatin marks, and are enriched for co-transcriptional 
splicing [36]. In “promoter-like” exons we found enriched ChIA-PET signal 
(indicative of an increase in looping and interaction with the promoter), in 
C-higher than C-lower conditions (Figures 6e). As a control, we did not find 
ChIA-PET signal enrichment in the set of all regulated exons (Figure S8). 
Figure 6f shows a “promoter-like” exon more included in Hela than in K562, 
exhibiting local peaks of DNase I, RNA Pol II, H3K9ac, H3K27ac and 
H3K4me3 in Hela, but not in K562. The exon also shows ChIA-PET tags 
only in Hela cells. 
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Discussion 
 
Regulated alternative splicing is assumed to contribute to cell type 
identity and methods have been developed which are able to predict tissue 
specific exon inclusion with high accuracy [37]. In our analysis, we found a 
relatively small number of human exons (about 3% of all exons) exhibiting 
regulated inclusion in a panel of human cell lines. This cannot be 
attributed to insufficient sampling by RNASeq, since ENCODE cell lines are 
sequenced in replicates at very high depth of coverage (around 240M 
reads per sample).  On the other hand, the diversity of biological samples 
used is certainly reduced, and cell lines are known to exhibit peculiar 
biology [38].  While regulated splicing, therefore, is likely to be more 
widespread than detected here,  our results could also suggest that the 
contribution of splicing regulation to defining cell type identity is exerted 
chiefly through a relatively small, but well defined, set of exons.   
Recent results have unveiled that pre-mRNA splicing occurs 
predominantly co-transcriptionally, thus providing a framework in which 
chromatin and transcription-related factors interact with the pre-mRNA 
processing machinery. However, among most exons with regulated 
inclusion we found in general, little direct association between differential 
inclusions and histone modifications. While these results are not fully 
unexpected, since splicing factors are likely to be the main players in 
splicing regulation, they somehow in contrast with reports of histone 
modifications influencing splicing outcomes through recruitment of 
splicing factors and through the modulation of RNA Pol II dynamics. 
Results – Part III 
 
 103 
Indeed, previous work linked high H3K9ac levels in the NCAM gene with 
fast elongating RNA Pol II and skipping of a specific exon [39]. High levels 
of H3K36me3 or H3K27me3 along the FGFR2 were correlated with the 
regulation of a mutually exclusive alternative splicing event [10]. In these 
cases, however, changes in histone modifications appear to spread over 
large regions covering the whole gene, while here we explicitly explored 
chromatin modifications local to the exons. More importantly, in our work 
we investigated only direct effects acting independently, and we ignored 
the role of high order interactions between different histone modifications 
and other elements of chromatin structure. These could actually configure 
a quite complex histone-based splicing regulatory code. Furthermore, we 
focused specifically in complete exon skipping events, and ignored other 
types of splicing events such as alternative splice site usage. In this regard, 
Tilgner et al. [21] found that nucleosome occupancy may contribute more 
strongly to the definition to the 3’ splice site. If so, histone modifications 
would also be expected to play a major role in the regulation of alternative 
3’ splice sites.  
While we did not found evidence for a general direct effect of 
chromatin structure in exon inclusion, we did identify a subgroup of 
regulated exons (about 4% of all regulated exons) for which co-occurrence 
of H3K9ac, H3K27ac and H3K4me3, histone modifications typically 
associated to promoters, strongly correlate with exon usage levels. This 
association is not biased by our discovery approach, since we replicated it 
in cell line comparisons that were not part of the training set. These 
“promoter-like” alternative exons appear predominantly in low abundance 
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isoforms, but in which, a significant increase in the density of histone 
modification correlates with an increase in the levels of exon inclusion. 
These observations suggest that chromatin architecture may play a more 
prominent role in the regulation of exon inclusion, under conditions of 
weak splice site recognition.  
We further related the accumulation of these histone modifications 
in highly included exons with higher occupancy of RNA Polymerase II. 
Accumulation of RNA Polymerase II has been linked to exon inclusion [40, 
41], associated with slower Pol II kinetics and consequently additional 
opportunities for splice site recognition before competing sites come into 
play [42]. However we also found higher inclusion of “promoter-like” exons 
in states of open chromatin, as measured by DNase I. This observation is 
somehow in contrast with previously proposed models linking closed 
chromatin and slower transcription elongation with increased exon 
inclusion [11, 43-45]. In particular for H3K9ac, previous studies reported a 
correlation between accumulation of this mark along the whole gene body 
(NCAM) and skipping of a specific alternative exon [45]. 
We also found that “promoter-like” exons, while no promoters 
themselves, they are, on average, closer to TSS and enriched by ChIA-PET 
tags associated with RNA Polymerase II. Thus, we hypothesize that, in 
these exons, splicing regulation is mediated by the promoter, either by 
formation of a DNA loop with the exon and helping chromatin marking 
and transcription factor binding extending from the TSS to the alternative 
exon, or by differential splice site pairing when an alternative TSS 
generates an alternative first exon (Figure 7). Recent work exploring the 
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three-dimensional structure of the genome reported physical links 
between internal exons and their associated promoter or enhancers. These 
results argue for an interplay between 3D-genome organization and 
alternative splicing regulation and warrant the systematic analysis of these 
associations in future studies using conformation capture technologies 
[46]. An alternative interpretation relies on the fact that H3K9ac, H3K27ac, 
H3K4me3, and DNase hypersensitive on “promoter-like” exons simply 
reflect open chromatin on these exons.  It is conceivable that binding of 
factors facilitated by the opening of chromatin influence splice site 
recognition either directly through their effects on splicing factor 
recruitment or through effects on RNA Pol II elongation - a mechanism 
resembling promotion of exon inclusion by CTCF [13].  
In summary, our work sheds light on functional connections 
between chromatin structure and pre-mRNA processing, establishing 
associations between epigenetic marks and differential exon inclusion and 
suggesting a role for promoter-like regions and 3-dimensional genome 
architecture in the regulation of the alternative splicing of certain exons. 
We specifically propose that in exons that are proximal to active promoter 
regions (either in linear or tri-dimensional space), open chromatin 
promotes exon inclusion, maybe by facilitating the recruitment of splicing 
factors. However, we want to stress that through our analysis we are 
unable to uncover the direction of the causation, and while histone 
modifications have been proposed to promote splicing, results have also 
been obtained suggesting that splicing can promote modification of 
histones by enhancing the recruitment of chromatin remodeling factors 
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[47]. Further research will be needed to work out their detailed molecular 
mechanisms behind these observations. 
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Methods 
 
Alternatively skipped exon calling 
Using the gencode [48] v15 annotation  we determined all exons 
that are  
1. internal in all transcripts they appeared in 
2. not overlapped by any non-identical exon in both annotations. 
Identity of exons is defined by their location (chromosome, start, 
end strand) 
3. between 50 and 450bps long 
4. at least 600nts away from the respective annotated TSS or TTS 
5. surrounded by AG-GT splice sites 
6. located on chromosomes 1-22 and X 
For the remaining exons, a two by two table was constructed 
containing junction inclusion reads and junction exclusion reads in the two 
cell types (cell1 and cell2) retaining only the exons with a minimum of 1 
junction inclusion read in cell1 and 1 exclusion read in cell2 or vice-versa. 
For every cell-pair, two one-sided Fisher tests were run and corrected for 
multiple testing in the Benjamini-Hochberg sense, resulting in three 
disjoint sets of exons: 
1. exons that are significantly more included in cell1 (which will be 
referred to as “more included”, even though the choice of the 
direction from cell1 to cell2 is clearly arbitrary) 
2. exons that are significantly less included in cell1 (which will be 
referred to as “less included”) 
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3. exons whose inclusion is not significantly changed between the two 
cell types (which will be referred to as “notAS exons” for the sake of 
conciseness and clarity, although “non-significant AS exons” would 
be more correct.)  
From the set of more and less included exons, we further selected 
the exons that met the following criteria:  
i. The expression of the gene containing the exon did not change 
more than 10fold between cell1 and cell2. To measure gene 
expression, we used CAGE tags mapping to the gene promoter (see 
below).  
ii. at least 75% of all positions in a 900bp window around the acceptor 
were uniquely mappable for 36mers (see below). 
iii. The inclusion levels of the exon changed by at least 0.1 or two-fold 
between the two cell lines. 
 
Genes frequently contained more than one alternatively spliced exon 
thus defined. In order to avoid gene specific bias that might be introduced 
by genes that contribute many alternative exons (as for example, the TTN 
gene where 212 exons passed the Fisher test), we chose only one up-
regulated and up to one down-regulated exon per gene: The exon with the 
lowest p-value among all exons for the gene in question.  
For non-AS exons a similar procedure was carried out, removing 
however the “inclusion changed by at least 0.1 or two-fold”-criterion and 
choosing the exon per gene whose estimated inclusion change was 
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minimal among all non-AS exons of that gene (instead of the exon with the 
smallest p-value). Figure S1 illustrates this approach. 
 
 
Exon triplets 
For each regulated exon and each cell type comparison, we defined 
two non-regulated exons: The closest up- and downstream exon that 
• appeared in a transcript together with the alternative exon 
• that showed Benjamini-Hochberg-corrected p-value of 0.05 or 
greater. 
 
Inclusion level calculation 
Inclusion level (IncLevel) is a measure defined to describe the 
splicing status of the exons. It is computed as a function of the reads 
arguing for the inclusion of the exon (JIR) and reads arguing for exclusion 
(JER). Formally it is 
 
 
A value of 0 represents a totally excluded exon, while a value of 1 
represents a totally included exon. IDR (Irreproducible Discovery Rate), a 
measure widely used within the ENCODE project to assess reproducibility 
between replicates [49], was applied at a level of 0.01 and only the exons 
passing this filtered were used in the remaining analysis. 
 
  
€ 
IncLevel= 0.5* JIR0.5*JIR + JER
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Splice site strength measure 
For each exon we used maxEnt [50]in order to calculate an acceptor 
score and a donor score and represented the “exon strength” by the sum 
of these two scores. 
 
Gene expression calculation 
We employed ENCODE provided CAGE-clusters filtered by an Hidden 
Markov Model algorithm to differentiate between 5’ capped termini of Pol 
II transcripts and recapping events, and scored according to number of 
constituent CAGE tags [25]. 
We associated CAGE-clusters to the closest TSS within a radius of 
100 nucleotides. We computed the expression of a given gene as the sum 
of the scores of CAGE-clusters associated to all gene’s TSS. 
 
Mappability calculation 
Mappability for the hg19 genome was calculated using the GEM-
mapper for 36bp and 75bp reads. For each acceptor in the genome, 
mappability was calculated in the direction of transcription.   
 
Exon selection for validation experiments 
Out of the exons that had cell type specific H3K9ac peaks that co-
occurred with high exon inclusion, we selected a total of 12 exons for 
validation by RT-PCR and ChIP. 
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Cell culture, RNA extraction and RT-PCR analysis  
K562 and Hela cells were grown in Dulbecco’s modified Eagle’s 
medium (Gibco BRL) supplemented with 10% of fetal bovine serum (FBS), 
penicillin and streptomycin. Gm12878 cells were grown in RPMI (INSERT 
REF), supplemented with 15%FBS (Gibco BRL), glycine (SEE), penicillin and 
streptomycin.  
Total RNA was isolated using Qiagen RNeasy mini kit and re-
suspended in RNAse-free water (Ambion). DNA digestion was performed 
using RNase-free DNase (Promega). DNA-free total RNA (1 µg) was used for 
RT−PCR using SuperScript III reverse transcriptase (Invitrogen), random 
hexamers and oligo dT. 5% of the reaction was used for Real Time PCR 
(Applied Biosystem) together with the primers (Table S2) following the 
manufacturer’s instructions. 
 
Chromatin immunoprecipitation (ChIP).  
Cells were plated at a density of 2X105 cells in 75 cm2  flasks and 
after 48h of culture, incubated with 1% (vol/vol) formaldehyde in culture 
medium for 10 minutes at room temperature. Cells were then washed in 
cold phosphate-buffered saline (PBS), harvested and lysed in a buffer 
containing 1% SDS, 10 mM EDTA and 50 mM Tris/HCl pH 8.1, and 
sonicated in 15ml tubes with Bioruptor UCD-200 Diagenode (ultrasonic 
wave output power 250W, 30” on-30”off, 4X10’) to yield chromatin sizes of 
150-300 bp. 100 µg of DNA/sample were used for immunoprecipitation 
with 5µg of anti-H3K9ac rabbit (ab4441), anti-H3 rabbit (ab1791) or 
control rabbit IgGs (Sigma-Aldrich). Co-precipitated DNA was then 
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analyzed by Quantitative real time PCR performed with Sybr Green mix 
(Applied Biosystem) according to manufacturer’s instructions. The 
antibody against total H3 was used for normalization as well as a control 
to exclude the possibility that the effects observed are caused by 
differences in nucleosome occupancy. The primers used are listed in the 
Supplementary Table 1. 
 
 Chromatin signature in exons 
To define the chromatin signature of each exon, we calculated the 
average of signal, per histone modification, from ENCODE normalized 
signal files in the exon region [51]. The same procedure was applied for 
the control, DNase I, ChIA-PET and transcription factors tracks. Wilcoxon 
signed-rank test, with Bonferroni correction for multiple testing, was used 
to assess the significance between the groups of exons. 
 
Exon clustering 
Alternative spliced exons differentially expressed between cell lines 
were partitioned according to their histone modifications and control 
levels using a k-means clustering approach. The method was applied to 
“higher included” and “lower included” exons separately. Exons falling in 
cluster 3 and 4 of “higher included” exons and in cluster 4 of “lower 
included” exons were merged in the group of “Promoter-like exons”. Each 
exon was thus associated with 2 cell lines, one in the “higher inclusion” 
group and one in the “lower inclusion” group. 
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Distance to closest annotated TSS 
The distance of an exon to the annotated TSS was calculated by 
measuring the genomic distance from the first nucleotide of the exon and 
the closest TSS from all the transcripts the exon belongs to. 
 
Distance to closest used TSS 
The distance of an exon to the closest used TSS was calculated by 
finding the closest CAGE-cluster with a minimum expression value of 1 
and calculating its genomic distance to the studied exon, in an annotation 
independent manner. 
 
Binding motifs analysis 
An hyper geometric test, with Benjamin Hochberg p-value correction, 
was applied to JASPAR CORE 2014[52] and MEME 4.4[53] databases 
looking for enrichment in binding transcription factor and RNA binding 
proteins motifs inside the exons respectively, in the “Promoter-like exons” 
versus the remaining differentially included identified exons. 
 
Splicing change in NHEK 
NHEK, a cell line not used in the discovery analysis of the paper, was 
used for validation of our findings. The difference in inclusion and in 
histone modification signal was calculated between NHEK and K562, Only 
exons with an inclusion difference larger than 0.1 were used. Total signal 
was calculated as the sum of H3K27ac, H3K4me3 and H3K9ac differences. 
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Only exons with a Total difference higher than 1 were considered as 
having chromatin differences. 
 
Exon inclusion in GTEx project 
We calculate inclusion levels, as described above, for the set of all 
internal exons in the 1,493 post-mortem samples available from the GTEx 
project. The samples are very heterogeneous, coming from up to 43 
different tissues from 175 individuals 
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JIR: Junction inclusion read 
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Description of additional data files 
The following additional data files are available with the online 
version of the paper. Additional files 1 and 2 contain the set of 
differentially included exons selected in all cell-pairs used, more and less 
included exons, respectively. These files are in bed format and field 4 is 
the cell-pair in which the exon was identified as regulated. Additional file 3 
contains the list of “promoter-like”, also in bed format. Additional file 4 
contains the supplementary figures and tables.  
 
Acknowledgements 
Research reported in this publication was supported by the NHGRI 
award 1U54HG007004, the Spanish Ministerio de Economia y 
Conocimiento (MINECO) grant BIO2011-26205 and the ERC/European 
Community PF7 grant 294653 RNA-MAPS. JC was supported by a 
SFRH/BD/33535/2008 from the Portuguese Foundation to Science and 
Technology. CI was supported by a La Caixa predoctoral fellowship. Work 
in JV’s lab was supported by Fundación Botín, by Banco de Santander 
through its Santander Universities Global Division and by Consolider 
RNAREG, MINECO and AGAUR. We thank Anshul Kundaje, Ben Brown, 
Michael Snyder and Thomas Gingeras for useful discussions and access to 
data. 
 
  
Results – Part III 
 
 117 
References 
 
 
1. Kim E, Magen A, Ast G: Different levels of alternative splicing 
among eukaryotes. Nucleic Acids Res 2007, 35:125-131. 
2. Nilsen TW, Graveley BR: Expansion of the eukaryotic proteome by 
alternative splicing. Nature 2010, 463:457-463. 
3. Fu XD, Ares M, Jr.: Context-dependent control of alternative 
splicing by RNA-binding proteins. Nat Rev Genet 2014, 15:689-701. 
4. Beyer AL, Osheim YN: Splice site selection, rate of splicing, and 
alternative splicing on nascent transcripts. Genes Dev 1988, 
2:754-765. 
5. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G: 
Multiple links between transcription and splicing. RNA 2004, 
10:1489-1498. 
6. Carrillo Oesterreich F, Preibisch S, Neugebauer KM: Global analysis 
of nascent RNA reveals transcriptional pausing in terminal exons. 
Mol Cell 2010, 40:571-581. 
7. Khodor YL, Rodriguez J, Abruzzi KC, Tang CH, Marr MT, 2nd, 
Rosbash M: Nascent-seq indicates widespread cotranscriptional 
pre-mRNA splicing in Drosophila. Genes Dev 2011, 25:2502-2512. 
8. Ameur A, Zaghlool A, Halvardson J, Wetterbom A, Gyllensten U, 
Cavelier L, Feuk L: Total RNA sequencing reveals nascent 
transcription and widespread co-transcriptional splicing in the 
human brain. Nat Struct Mol Biol 2011, 18:1435-1440. 
9. Tilgner H, Knowles DG, Johnson R, Davis CA, Chakrabortty S, Djebali 
S, Curado J, Snyder M, Gingeras TR, Guigo R: Deep sequencing of 
subcellular RNA fractions shows splicing to be predominantly co-
transcriptional in the human genome but inefficient for lncRNAs. 
Genome Res 2012, 22:1616-1625. 
10. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli 
T: Regulation of alternative splicing by histone modifications. 
Science 2010, 327:996-1000. 
Results – Part III 
 
 118 
11. de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein Ma, Pelisch 
F, Cramer P, Bentley D, Kornblihtt AR: A Slow RNA Polymerase II 
Affects Alternative Splicing In Vivo. Mol Cell 2003, 12:525-532. 
12. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CW: Co-
transcriptional commitment to alternative splice site selection. 
Nucleic Acids Res 1998, 26:5568-5572. 
13. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev 
M, Oberdoerffer P, Sandberg R, Oberdoerffer S: CTCF-promoted 
RNA polymerase II pausing links DNA methylation to splicing. 
Nature 2011, 479:74-79. 
14. Andersson R, Enroth S, Rada-Iglesias A, Wadelius C, Komorowski J: 
Nucleosomes are well positioned in exons and carry 
characteristic histone modifications. Genome Res 2009, 19:1732-
1741. 
15. Hon G, Wang W, Ren B: Discovery and annotation of functional 
chromatin signatures in the human genome. PLoS Comput Biol 
2009, 5:e1000566. 
16. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J: 
Differential chromatin marking of introns and expressed exons 
by H3K36me3. Nat Genet 2009, 41:376-381. 
17. Nahkuri S, Taft RJ, Mattick JS: Nucleosomes are preferentially 
positioned at exons in somatic and sperm cells. Cell Cycle 2009, 
8:3420-3424. 
18. Schwartz S, Meshorer E, Ast G: Chromatin organization marks 
exon-intron structure. Nat Struct Mol Biol 2009, 16:990-995. 
19. Spies N, Nielsen CB, Padgett RA, Burge CB: Biased chromatin 
signatures around polyadenylation sites and exons. Mol Cell 2009, 
36:245-254. 
20. Iannone C, Pohl A, Papasaikas P, Soronellas D, Vicent GP, Beato M, 
Valcarcel J: Relationship between nucleosome positioning and 
progesterone-induced alternative splicing in breast cancer cells. 
RNA 2015. 
Results – Part III 
 
 119 
21. Tilgner H, Nikolaou C, Althammer S, Sammeth M, Beato M, Valcarcel 
J, Guigo R: Nucleosome positioning as a determinant of exon 
recognition. Nat Struct Mol Biol 2009, 16:996-1001. 
22. Enroth S, Bornelov S, Wadelius C, Komorowski J: Combinations of 
histone modifications mark exon inclusion levels. PLoS One 2012, 
7:e29911. 
23. An integrated encyclopedia of DNA elements in the human 
genome. Nature 2012, 489:57-74. 
24. A user's guide to the encyclopedia of DNA elements (ENCODE). 
PLoS Biol 2011, 9:e1001046. 
25. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, 
Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of 
transcription in human cells. Nature 2012, 489:101-108. 
26. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, 
Kingsmore SF, Schroth GP, Burge CB: Alternative isoform 
regulation in human tissue transcriptomes. Nature 2008, 
456:470-476. 
27. Magen A, Ast G: The importance of being divisible by three in 
alternative splicing. Nucleic Acids Res 2005, 33:5574-5582. 
28. Zheng CL, Fu XD, Gribskov M: Characteristics and regulatory 
elements defining constitutive splicing and different modes of 
alternative splicing in human and mouse. RNA 2005, 11:1777-
1787. 
29. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, 
Chepelev I, Zhao K: High-resolution profiling of histone 
methylations in the human genome. Cell 2007, 129:823-837. 
30. Hoffman MM, Buske OJ, Wang J, Weng Z, Bilmes JA, Noble WS: 
Unsupervised pattern discovery in human chromatin structure 
through genomic segmentation. Nat Methods 2012, 9:473-476. 
31. Kundaje A, Kyriazopoulou-Panagiotopoulou S, Libbrecht M, Smith CL, 
Raha D, Winters EE, Johnson SM, Snyder M, Batzoglou S, Sidow A: 
Ubiquitous heterogeneity and asymmetry of the chromatin 
Results – Part III 
 
 120 
environment at regulatory elements. Genome Res 2012, 22:1735-
1747. 
32. Consortium G: The Genotype-Tissue Expression (GTEx) project. 
Nat Genet 2013, 45:580-585. 
33. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR: 
Rapid and phosphoinositol-dependent binding of the SWI/SNF-
like BAF complex to chromatin after T lymphocyte receptor 
signaling. Cell 1998, 95:625-636. 
34. Kodzius R, Kojima M, Nishiyori H, Nakamura M, Fukuda S, Tagami M, 
Sasaki D, Imamura K, Kai C, Harbers M, et al: CAGE: cap analysis of 
gene expression. Nat Methods 2006, 3:211-222. 
35. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, 
Velkov S, Ho A, Mei PH, et al: An oestrogen-receptor-alpha-bound 
human chromatin interactome. Nature 2009, 462:58-64. 
36. Mercer TR, Edwards SL, Clark MB, Neph SJ, Wang H, Stergachis AB, 
John S, Sandstrom R, Li G, Sandhu KS, et al: DNase I-hypersensitive 
exons colocalize with promoters and distal regulatory elements. 
Nat Genet 2013, 45:852-859. 
37. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, 
Hua Y, Gueroussov S, Najafabadi HS, Hughes TR, et al: RNA splicing. 
The human splicing code reveals new insights into the genetic 
determinants of disease. Science 2015, 347:1254806. 
38. Lukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, Huber W, 
Ukkonen E, Brazma A: A global map of human gene expression. 
Nat Biotechnol 2010, 28:322-324. 
39. Schor IE, Gomez Acuna LI, Kornblihtt AR: Coupling between 
transcription and alternative splicing. Cancer Treat Res 2013, 
158:1-24. 
40. de la Mata M, Lafaille C, Kornblihtt AR: First come, first served 
revisited: factors affecting the same alternative splicing event 
have different effects on the relative rates of intron removal. 
RNA 2010, 16:904-912. 
Results – Part III 
 
 121 
41. Dujardin G, Lafaille C, de la Mata M, Marasco LE, Munoz MJ, Le 
Jossic-Corcos C, Corcos L, Kornblihtt AR: How slow RNA 
polymerase II elongation favors alternative exon skipping. Mol 
Cell 2014, 54:683-690. 
42. Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ: 
Alternative splicing: a pivotal step between eukaryotic 
transcription and translation. Nat Rev Mol Cell Biol 2013, 14:153-
165. 
43. Allo M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, 
Agirre E, Plass M, Eyras E, Elela SA, et al: Control of alternative 
splicing through siRNA-mediated transcriptional gene silencing. 
Nat Struct Mol Biol 2009, 16:717-724. 
44. Saint-Andre V, Batsche E, Rachez C, Muchardt C: Histone H3 lysine 
9 trimethylation and HP1gamma favor inclusion of alternative 
exons. Nat Struct Mol Biol 2011, 18:337-344. 
45. Schor IE, Kornblihtt AR: Playing inside the genes: Intragenic 
histone acetylation after membrane depolarization of neural 
cells opens a path for alternative splicing regulation. Commun 
Integr Biol 2009, 2:341-343. 
46. Dekker J, Marti-Renom MA, Mirny LA: Exploring the three-
dimensional organization of genomes: interpreting chromatin 
interaction data. Nat Rev Genet 2013, 14:390-403. 
47. de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, Andrade J, 
Levezinho H, Gut M, Eick D, Gut I, et al: Splicing enhances 
recruitment of methyltransferase HYPB/Setd2 and methylation of 
histone H3 Lys36. Nat Struct Mol Biol 2011, 18:977-983. 
48. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, 
Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al: 
GENCODE: the reference human genome annotation for The 
ENCODE Project. Genome Res 2012, 22:1760-1774. 
49. Li JJ, Jiang CR, Brown JB, Huang H, Bickel PJ: Sparse linear modeling 
of next-generation mRNA sequencing (RNA-Seq) data for isoform 
Results – Part III 
 
 122 
discovery and abundance estimation. Proc Natl Acad Sci U S A 
2011, 108:19867-19872. 
50. Yeo G, Burge CB: Maximum entropy modeling of short sequence 
motifs with applications to RNA splicing signals. J Comput Biol 
2004, 11:377-394. 
51. Hoffman MM, Ernst J, Wilder SP, Kundaje A, Harris RS, Libbrecht M, 
Giardine B, Ellenbogen PM, Bilmes JA, Birney E, et al: Integrative 
annotation of chromatin elements from ENCODE data. Nucleic 
Acids Res 2013, 41:827-841. 
52. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B: 
JASPAR: an open-access database for eukaryotic transcription 
factor binding profiles. Nucleic Acids Res 2004, 32:D91-94. 
53. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li 
WW, Noble WS: MEME SUITE: tools for motif discovery and 
searching. Nucleic Acids Res 2009, 37:W202-208. 
 
 
  
  
Results – Part III 
 
 123 
 
  
Results – Part III 
 
 124 
 
  
Results – Part III 
 
 125 
 
  
Results – Part III 
 
 126 
 
Results – Part III 
 
 127 
  
Results – Part III 
 
 128 
 
Results – Part III 
 
 129 
  
Results – Part III 
 
 130 
Figure Legends 
 
Figure 1. Assessment and properties of exons differentially 
spliced between cell lines K562 and Gm12878. (a) Classification of 
“more included” and “less included” exons. (b) Estimated inclusion ratio in 
the K562 cell line (x-axis) and in the Gm12878 cell line (y-axis) of exons 
whose inclusion is (i) significantly higher in Gm12878 (dark blue), (ii) 
significantly higher in the K562 cell line (dark red), (iii) whose inclusion 
does not change significantly between the two cell lines (light blue). (c) 
Distribution of the sum of the strengths of 5’ and 3’ splice sites flanking 
exons that do not display significant differences in inclusion between the 
cell lines (notAS, left boxplot) and differentially included (i.e. regulated) 
exons (AS, right boxplot). Wilcoxon rank-sum-tests were calculated for the 
two distributions, significance levels are indicated: * (0.05>p>0.01), ** 
(0.01>p>0.001), *** (0.001>p). (d) Exon length distribution of AS and 
notAS exons. (e) Fraction of AS and notAS exons, the length of which is 
multiple of three: only exons that were entirely coding were considered. (f) 
Expression of genes with exons whose inclusion is (i) significantly higher 
in Gm12878 (dark blue), (ii) significantly higher in the K562 cell line (dark 
red).  X-axis: log2(cage value) in K562; Y-axis: log2(cage value) in 
Gm12878. (g) Experimental validation: comparison between inclusion 
levels of differentially regulated exons between Gm12878 and K562, 
calculated analyzing RNASeq ENCODE data (gray bars) or with RT-qPCR 
analyses of RNA extracted from K562 and Gm12878 (green bars). For RT-
qPCR analysis were used primers amplifying specifically the inclusion or 
skipping isoform. Gray bars represent log2 ratio of inclusion level between 
Gm12878 and K562 calculated for each exon form RNASeq. Green bars 
represent log2 ratio between inclusion/skipping ratio in Gm12878 and 
K562, normalized to the ratio in a constitutive exon on the same 
transcript; error bars represent standard deviations of three independent 
experiments. 12 out of 15 exons tested show consistent inclusion 
direction as measured by RNASeq and RT-qPCR.  
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Figure 2. Differentially spliced exons in cell lines. (a) Inclusion 
range of regulated exons. The inclusion range of an exon is defined as the 
difference between the maximum and the minimum inclusion observed for 
that exon across the cell lines investigated. Exons are sorted by inclusion 
range. (b) Distribution of the inclusion level of regulated (AS) and non-
regulated exons (notAS) across all the cell lines used.  
 
Figure 3. Enrichment of chromatin epigenetic marks on regulated 
exons. (a) Differential signals (log2, Y-axis) for “more included” (blue) or 
“less included” (red) exons from the seven cell-pairs used, are represented 
for 11 ChIPSeq datasets corresponding to different epigenetic marks, CTCF 
and input DNA (control). The boxplots correspond to the distribution of 
the average differential signal over the length of each regulated exon.  
Wilcoxon rank-sum-tests with Bonferroni correction were calculated for the 
two distributions, significance levels are indicated: * (0.05>p>0.01), ** 
(0.01>p>0.001), *** (0.001>p). CTCF, H3K9ac, H3K4me3 and H3K27ac 
have significantly higher signal in “more included” than in “less included” 
exons, while input DNA control shows the opposite trend. (b) Validation of 
H3K9ac enrichment over H3 by ChIP. Average and standard deviation of 
log2 of the fold change in H3K9ac signal over total H3 signal in regulated 
(alternative) and constitutive exons from four different genes. Values are 
from three independent replicates. White bars in the lower panel represent 
inclusion level ratios between the two cell lines for the regulated exons, as 
determined by RNASeq.  A general association between exon inclusion and 
higher levels of H3K9 acetylation is observed. (c-f) Differential ChIPSeq 
signals (average and standard error of the mean) for CTCF, H3K9ac, 
H3K27ac, and H3K4me3 are represented for “more included” exons (blue) 
and “less included” exons (red) in a 800bp-window around the middle of 
the regulated exon (AS) and flanking not regulated (notAS) upstream (left) 
and downstream  (right) exons. Significance levels are indicated by * 
(0.05>p>0.01), ** (0.01>p>0.001), *** (0.001>p) and ns (p>0.05). 
Differential accumulation of marks is generally specific of regulated exons.  
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Figure 4. K-means clustering based on epigenetic signatures of 
regulated exons. (a, b) boxplots represent differential ChIPSeq signal for  
more included (a) and less included (b) exons. Each square represents one 
group of exons identified by K-means clustering. The number of exons 
present in each cluster is indicated to the left of each cluster. 3 clusters of 
exons show strong differential signal for H3K9ac, H3K27ac and H3K4me3 
in the direction of the inclusion level change. These exons were called 
“promoter-like” exons due to the nature of these histone modifications. 
 
Figure 5. Characterization of “promoter-like” exons. (a) Exon 
inclusion levels in C-higher (yellow) and C-lower (blue) cell lines in 
“promoter-like” and non “promoter-like” exons. (b) Transcription factors 
binding enrichment significance in C-higher over C-lower cell lines. 
Bonferroni corrected –log10(p-value) of the enrichment is represented for 
all the transcription factors tested. All the transcription factors had higher 
signal in C-higher (orange). Solid colors represents significant enrichments 
(p < 0.05) (c-d) DNase I sensitivity and RNA polymerase II signals in 
promoter-like exons in C-higher and C-lower cell lines. Signals are 
represented for regulated (AS) and flanking non-regulated (notAS) exons. 
(e) Gene expression levels of exons in C-higher and C-lower conditions 
measured using CAGE tags. Distributions are given for “bona-fide” 
annotated TSSs and for “promoter-like” exons location.  Significance levels 
are indicated by * (0.05>p>0.01), ** (0.01>p>0.001), *** (0.001>p) and ns 
(p>0.05). 
 
Figure 6. Relationship between promoter and “promoter-like” 
exons  (a) Distribution of the distance (in nucleotides) between annotated 
TSS of “promoter-like” and non “promoter-like” exons. (b) Distribution of 
the distance (in nucleotides) between “promoter-like” exons and the 
nearest active TSS in C-higher and C-lower cell lines. (c) Proportion of 
“promoter-like” exons in which the active TSS is closer in C-higher than in 
C-lower cell lines, in C-lower than in C-higher cell lines, and at the same 
distance in C-higher and C-lower cell lines. (d) USCS Genome browser view 
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of the DENND3 gene, that contains a “promoter-like” exon (in red) more 
included in Hela than in Gm12878 cells.  Genomic tracks for CAGE, DNase 
I and ChIPSeq of H3K9ac, H3K27ac and H3K4me3 levels are displayed. The 
CAGE signal corresponding to the alternative active promoter, used in Hela, 
is marked with a red arrow. (e) CHIA-PET signal in “promoter-like” exons in 
C-higher and C-lower cell lines. Signals are represented for regulated (AS) 
and flanking non-regulated (notAS) exons. Significance levels are indicated 
by * (0.05>p>0.01), ** (0.01>p>0.001), *** (0.001>p) and ns (p>0.05). (f) 
USCS Genome browser view of the P4HA1 gene, that contains an exon (in 
red) more included in Hela than in K562 cells.  Genomic tracks for DNase I, 
ChIA-PET and ChIPSeq of Pol II, H3K9ac, H3K27ac and H3K4me3 are 
displayed. The ChIA-PET signal, specific of Hela cells, is marked with a blue 
arrow. 
 
Figure 7. Models linking promoter activity with inclusion of 
“promoter-like” exons. Looping model (a): physical interactions between 
TSS and the genomic region corresponding to the alternative exon 
facilitates exon inclusion (left), while absence of such interactions leads to 
more skipping of “promoter-like” exons (pink). Alternative TSS model (b): 
the activation of an alternative TSS in the proximity of the genomic region 
corresponding to the alternative exon facilitates exon inclusion (left), while 
the inactivation of the TSS closer to the “promoter-like” exon promotes its 
skipping. 
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CHAPTER 4 – DISCUSSION 
 
Genomic DNA, in eukaryotes, is packed into nucleosomes, octamers 
of histone proteins around which DNA is wrapped. Histone tails are subject 
to a vast array of post-translational modifications including acetylation and 
methylation. These modifications convert chromatin between “closed” 
heterochromatin and more “open” euchromatin states creating a constant 
state of flux. Since most of gene expression steps, from transcription to 
RNA processing, happen in a chromatin context it is widely accepted that 
there are connections between them. Levels of histone modifications 
throughout the gene are associated with regulation at the initiation and 
elongation steps of transcription (Li, Carey, and Workman) and specific 
accumulation of certain chromatin marks over the exons were already 
associated with splicing regulation (Luco and Misteli). However, in most of 
the cases, evidence remains correlative in nature and we still lack a 
rigorous mechanistic proof of such event.  
In the frame of this thesis work, we aimed to better understand 
connections between chromatin structure and RNA production. With the 
advent of high-throughput sequencing techniques great amounts of data 
was generated, published and shared with the community. Cases like the 
ENCODE (Dunham et al.) or modENCODE (Roy et al.; Gerstein et al.) 
consortiums made a great effort in making everything public and ready to 
be used by the community. In this thesis we took advantage of this 
opportunity and analyzed both public available and privately generated 
data in the pursuit of our answers. 
In the first section of the results chapter we re-visited gene 
expression in the context of chromatin by studying the regulation of 
developmental temporally active genes. We observed that the regulation of 
these specific genes happens in the absence of canonically active histone 
modifications, possibly depending more on the binding of transcription 
factors. At the same time we found that chromatin states correlate with 
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expression stability (both at the transcription and splicing level) and not 
only with expression level. Another of our topics of interest is splicing and 
so, in the second section of the results, we studied the “co-
transcriptionality” of RNA splicing. Beyer and Osheim put forward for the 
first time, in 1988, the idea that splicing could occur co-transcriptionally. 
Only now we had the tools to confirm that this was actually a very frequent 
phenomenon. A series of independent, concurrent studies showed that 
chromatin follows an intron-exon structure and that nucleosomes are 
especially enriched in exons when compared to exons(Nahkuri, Taft, and 
Mattick; Schwartz, Meshorer, and Ast; Spies et al.; Tilgner, Nikolaou, et al.). 
Knowing that splicing, globally, occurs while the pre-mRNA is still tethered 
to the transcribing RNA polymerase, the role of chromatin in splicing 
regulation was the logical question that arose right after. In the third 
section of the results we decided to compare changes in chromatin 
structure co-occurring with changes in splicing decisions between 
differentiated cell lines. The goal was to define a set of exons whose 
splicing decisions were under strong chromatin regulation and to propose 
a possible model to this process.  
 
 
A. Transcriptional activation without chromatin marking in 
developmentally regulated genes 
 
Regulation of gene expression is crucial to maintain cell identity but, 
throughout the lifetime of an organism, it also needs to be flexible enough 
to allow for responses to endogenous and exogenous stimuli. 
Development of an organism is a process that needs quick and accurate 
regulation and coordination of the cells. Modifications on DNA and on the 
histone proteins are known to control gene expression by establishing and 
maintaining specific chromatin states but in recent years it became evident 
that there were exceptions. Since regulated activation and de-activation of 
genes is particularly important and precise during morphogenesis, we 
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decided to study the chromatin context of temporarily active genes and to 
check if it followed tightly their activation. 
In this project we analyzed publicly available modENCODE ChIPSeq 
and RNASeq data in D. melanogaster and C. elegans and also generated 
some additional data for deeper exploration. We reported transcriptional 
activation of developmental regulated genes in the absence of canonically 
active chromatin marks. Genes that are temporarily active don’t have the 
typical histone marks of active genes and this finding is strongly 
supported by targeted validation experiments. These genes seem to have 
under stronger promoter regulation, as they are under stronger selective 
constrains, have enrichment of putative sites for transcription factors and 
also show different transcription factors binding profiles.  
Another finding we made was the positive correlation between 
canonically activator histone marks and RNA producing stability. Genes 
with stronger active histone modification marking have a more stable 
expression level, during development. We also reported an association 
between highly structured chromatin states and regulation of splicing. 
Indeed, we observed more stochastic production of alternative splicing 
isoforms in unmarked, developmentally regulated genes than in marked 
stably expressed ones. 
Overall, our results lead us to hypothesize two major transcriptional 
regulatory programs: In constitutively expressed genes, strong chromatin 
marking leads to stable transcriptional activity and tightly controlled RNA 
production with a comparatively smaller role of transcription factors; In 
genes needing rapidly activation/de-activation a more flexible, unmarked 
chromatin state is observed with transcription factors assuming the 
predominant role.  
 
 
  
Discussion 
 
 138 
B. Frequency of co-transcriptional splicing in humans 
 
When different steps in mRNA biogenesis occur at the same time 
and place there are opportunities for coupling or cross talk. During gene 
expression, if the act of intron removing happens in close proximity and 
while RNA polymerase is still transcribing the DNA, it opens a wealth of 
opportunities for chromatin to influence splicing. The possibility for 
regulation comes not only from the spatial proximity but also because 
chromatin can influence transcription dynamics, which in turn can 
influence exon inclusion levels in a feedforward and feedback kind of 
circuit (Mata et al.; Howe, Kane, and Ares). Here we decided to assess the 
frequency of co-transcriptional splicing, in the framework of the ENCODE 
project. 
We started by introducing the “completed splicing index” (coSI) for 
each exon in different RNASeq experiments, coming from different 
fractions/compartments of the cell. By analyzing RNASeq data coming 
from the chromatin fraction (the sequenced RNA was still being 
transcribed and in contact with the chromatin) and the nuclear polyA- 
fraction (transcribed RNA without polyA tail) we concluded that co-
transcriptional splicing is widespread in humans. Splicing also tends to 
proceed in a 5’ to 3’ direction, fitting with the “first come first served” rule, 
although exceptions exist.  
Exons showed differences in splice site strength, binding sites for SR 
proteins and hnRNPs and chromatin organization depending on how much 
splicing was completed. Since chromatin structure and Pol II occupancy 
change along the gene body (Barski et al.), as coSI does, the chromatin 
observation might reflect the position within the gene. This correlation 
might be functional or completely circumstantial. Nevertheless, decision 
tree analysis showed that chromatin contains predictive capacity for 
separating exons with high and low coSI, early and late spliced, 
respectively. This predictive capacity did not entirely came from the 
position within the gene (distance to TSS and polyA-site). Completion of 
splicing in lncRNAs seems to be less efficient than in protein coding genes. 
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CoSI values of lncRNAs are dramatically lower than those of coding exons 
in the chromatin fraction and persist in the nuclear polyA+ fraction. 
LncRNAs are often spliced later or not spliced at all, suggesting a less 
important role for splicing in non-coding RNAs. 
This project presents another piece of evidence that chromatin, 
transcription and splicing are connected and cannot always be completely 
separated. 
 
 
C. Co-occurrence of promoter-like chromatin marks and splicing 
regulation 
 
Using a statistical framework we carried out pairwise comparisons 
between differentiated human cell lines. We evaluated changes in splicing 
and changes in chromatin and tried to identify co-occurrence of both in 
order to capture exons whose splicing decisions could be influenced by 
epigenetic features. This link was already studied in the recent past and 
some histone marks were already reported as connected with splicing by 
recruiting splicing factors or, indirectly, by modulating RNA polymerase II 
dynamics in specific exons (Luco, Allo, et al.). With a different approach 
than these studies, we decided to take advantage of the ENCODE 
consortium data to study this connection genome-wide.  We used polyA+ 
nuclear RNASeq to identify differentially usage of exons between cell-lines 
and, to our surprise, only 3% of the evaluated exons could be found as 
significantly regulated among the five human cell-lines used. These exons 
are also characterized by a low level of inclusion when compared with the 
majority of the exons. With ChIPSeq data from different histone 
modifications we found a positive correlation between accumulation of 
H3K9ac, H3K27ac, H3K4me3 and CTCF and higher inclusion levels in the 
regulated exons. We also noticed that the accumulation of this histone 
marks was local and limited to the alternative exon cassette.  
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Since we believe that not all internal exons can be susceptible of 
chromatin regulation during transcription we decided to perform 
clustering analysis by the chromatin profiles. Strikingly we identified a 
smaller subset of exons in which histone modification levels changes 
between cell lines were very dramatic and always in the same direction for 
all the marks monitored. These exons were highly marked by H3K9ac, 
H3K27ac and H3K4me3 in the cell line with higher inclusion level and the 
levels occupancy of these marks was enough to predict splicing changes of 
these exons even in cell lines not used for the discovery. Since these 
histone marks are characteristic of promoter regions we called these 
exons “promoter-like” exons. In this line of thought we also found 
significant enrichment of RNA polymerase II signal, DNase I 
hypersensitivity signal and transcription factors binding in the cell-line of 
higher exon usage. 
Interestingly these “promoter-like” exons are also (linear or three 
dimensional) proximal to the active promoters. Recent work reported that 
some internal exons are marked by an enhancer-like and promoter-like 
signature due to a physical association through looping between the exon 
and its promoter or enhancer (Mercer et al.). We found enrichment of ChIA-
PET signals in the cell line of higher inclusion, suggesting the existence of 
long-range interaction between these exons and the promoters with an 
influence in splicing regulation. 
The accumulation of H3K4me3, H3K27ac and H3K9ac together with 
stronger DNase hypersensitive sites implies that these exons lie down in 
regions of open chromatin. Although this evidence should lead to faster 
elongation rates (and therefore more skipping), the accumulation of RNA 
polymerase II states for the opposite. We do indeed know that these exons 
have higher inclusion levels and therefore the stalling of polymerase could 
be due to some other factors binding in these DHS marked exons. Some of 
the transcription factors found enriched in conditions of higher inclusion 
were already implicated in splicing, like the Brg1. 
Our results argue for a promoter-associated chromatin role in the 
regulation of alternative splicing of low usage exons. Mediated by the 
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proximity to the active transcription start site, either in a linear way or by 
specific three-dimensional organization of the genome, the local re-
arrangements of chromatin in these promoter-like exons can facilitate the 
binding of external factors, with regulatory functions, that make these 
exons more included than in the absence of these context. These 
observations should be further validated and complemented with analysis 
of the conformation capture technologies to understand the underlying 
molecular mechanisms. 
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CHAPTER 5 – CONCLUSIONS 
 
Part I 
 
1. Transcription of temporally active genes during fly and yeast 
development occurs mostly in the absence of histone modifications 
canonically linked to gene activation 
 
2. Strong chromatin marking is also associated with expression 
stability and not only with expression level 
 
3. Highly structured chromatin state favors regulated exon inclusion 
and, consistently, unmarked genes exhibit a more stochastic 
alternative splicing pattern than marked stably expressed genes 
 
4. In genes that are constitutively expressed, strong chromatin 
marking leads to transcriptional stability and tightly controlled RNA 
production. In these genes, regulation by Transcription Factors 
would play a comparatively minor role. In contrast, genes that need 
to be rapidly activated and de-activated are characterized by an 
unmarked chromatin state that leads to a less regulated, more 
stochastic RNA production. In these genes, Transcription Factors 
would play the predominant regulatory role.  
 
Part II 
 
1. Co-transcriptional splicing is a reality for the majority of the human 
exons 
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2. Splicing tends to proceed in a 5’ to 3’ direction, fitting with the “first 
come first served” rule 
 
3. Most of the splicing events are finished before the polyA tail is 
added to the transcripts 
 
4. LncRNAs are often spliced later or not spliced at all, suggesting a 
less important role for splicing in non-coding RNAs. 
 
 
Part III 
 
1. Only a minority of the internal human exons is differentially spliced 
between human cell lines. These exons are characterized by a 
relatively low usage level. 
 
2. From this exon set, only a fraction show a strong correlation 
between inclusion levels and chromatin levels 
 
3. In these chromatin-associated exons, levels of H3K9ac, H3K27ac, 
H3K4me3, DNase I hypersensitivity, Pol II and various transcription 
factors, typical marks of promoters, are found positively associated 
with their inclusion levels 
 
4. These observations suggest a functional role for transcription-
activator chromatin features in the splicing regulation of alternative 
exons in close proximity 
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Gene expression without canonical chromatin marking in 
developmentally regulated genes 
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Supplementary Figure 1: Developmentally stable and regulated genes in D. melanogaster. a, Time 
points selected for the analysis of chromatin marking in genes regulated during fly development. From the 
available modENCODE RNASeq data, we selected the 12 points for which ChIPSeq experiments on histone 
modifications were also available.. b, Expression of one stable (NUCB1) and one developmentally regulated 
gene (Cy30401). The value of the coefficient of variation (cv) for NUCB1 is 0.15. Cy30401 in contrast, shows a 
peak of expression in one embryonic stage and, consistently, its cv is 2.49. c, Distribution of the coefficient of 
variation on fly genes. We have calculated the cv of expression for the 12,867 genes for which modENCODE 
has expression data along Drosophila development. The cv distribution uncovers a large class of genes with low 
coefficient of variation (constant expression during development), and two other minor classes containing genes 
whose expression is highly variable during development—often restricted to a limited set of stages. For most of 
the analysis we arbitrarily considered the top 1,000 genes with the lowest cv as stable, and, the top 1,000 genes 
with the highest cv as developmentally regulated genes (Supplementary Fig. 4). d, Time point of maximum 
expression of developmentally regulated genes. 
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Supplementary Figure 2: Chromatin marking at stable, regulated and silent genes. We performed 
a number of controls to rule out that our observations arise from undetected confounding factors a, Normalized 
levels of H3K4me3, H3K9ac, H3K4me1, H3K27ac, H3K27me3 and H3K9me3 at the time point of maximum 
expression during D. melanogaster development. Since there are differences in the heights between 
modENCODE ChIPSeq tracks, we first identified the highest peak of each mark in the genome by checking all 
the expressed genes and next we used this value to normalize the corresponding profiles. The distributions 
correspond to  the maximum height of the ChIPSeq peak within the gene body for H3K4me3, H3K9ac, 
H3K4me1 and H3K27ac, and the average height of the ChIPSeq signal over the gene body for H3K27me3 and 
H3K9me3. Patterns are the same, or even stronger, than those in Figure 1b. b, Distribution of expression of top 
1,000 stable, top 1,000 regulated, 1,000 silent genes, and of the set of top 1,000 regulated genes divided into 
three groups according to expression (low, medium, high) at the time point of maximum expression for each 
gene during fly development. Gene expression was computed as FPKMs by the modENCODE consortium. This 
was done to control for the differences in the dispersion of gene expression between stable and regulated genes.  
c, Levels of H3K4me3 at the time point of maximum expression during development.for the gene sets defined in 
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b. Values represent the maximum height of the ChIPSeq peak within the gene body. There is no effect of  
differences  in dispersion of expression, or of the magnitud of expression itself in the patterns observed in Figure 
1b d, Levels of H3K4me3 at the time point of maximum gene expression computed as the average signal over 
the gene body, instead of as the maximum peak. The pattern is the same than that in Figure 1b. e, Length of 
stable and regulated genes. Developmentally regulated genes have less number of exons than stable genes (2.6 vs 
5.7 on average) and shorter introns (600 bp vs 1,000 bp) and, as a consequence, regulated genes are shorter than 
stable genes (1,136 bp vs 2,864 bp). To rule out that gene size is a confounding factor, we selected the 520 
shortest stable genes. These have an average length (1,188 bp) and number of exons (2.6) very similar to that of 
variable genes. The figure shows the size distribution of genes in the different classes. f, H3K4me3 maximum 
peak at short stable genes is comparable to the peak at the previous set of stable genes, and it is much higher than 
the H3K4me3 peak at regulated genes. Therefore, there is no effect of gene length and number of exons in our 
observations. 
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Supplementary Figure 3: Profiles of H3K4me3 along fly development for apterous (ap), a stable 
gene, and Blastoderm-specific gene 25A (Bsg25A), an embryo-specific gene. The expression (measured as 
FPKMs) along these points is given on the left. In situ hybridizations images obtained from BDGP1 correspond 
to stages 13-16 (9-16h after egg laying) for ap and 1-6 (0-3h after egg laying) for Bsg25A, and show that these 
two genes have comparable restricted expression patterns.  
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Supplementary Figure 4: Partition of the entire set in stable and regulated genes. a, Distribution 
of the coefficient of variation on fly genes. The distribution of the coefficient of variation of gene expression 
along fly development reveals one major class of stable genes (P1), and two minor classes of genes that vary 
expression (P2 and P3). b, Number of genes belonging to each class. c, Distribution of gene expression levels at 
the developmental time point of maximum gene expression in each class. Gene expression is measured as 
FPKM by the modENCODE consortium d, Distribution of histone modifications at the time point of maximum 
gene expression in each gene class.  
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Supplementary Figure 5: Levels of H3K27me3 and H3K9me3 marking in stable and silent genes. 
a, Left panel: H3K27me3 in stable genes. As expected, most genes do not show H3K27me3. Right panel: 
H3K27me3 in silent genes. Many genes show either none or very low levels of H3K27me3. b, Left panel: 
H3K9me3 in stable genes. Most of genes do not show H3K9me3. Right panel: H3K9me3 in silent genes. Many 
genes show either none or very low levels of H3K9me3. 
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Supplementary Figure 6: Expression of stable genes, regulated genes broadly expressed at L3, 
silent genes, and stably expressed tissue-specific genes in six different tissues at L3. Expression levels, 
measured as FPKM by the modENCODE consortium, of six different tissues. The expression of stable tissue-
specific genes is given for each tissue separately in the following order: Carcass, Central nervous system, 
Digestive system, Fat body, Imaginal discs, and Salivary glands. Regulated broadly expressed genes show 
higher expression than stable tissue-specific genes even in the tissue in which the later are expressed, except in 
Imaginal discs.  
 
  
Supplementary material – Part I 
 
164 
 
 
 
Supplementary Figure 7: RNASeq and ChIPSeq analysis of Wing (WID) and Eye-antenna (EID) 
imaginal discs. a, RNASeq mapping and quantification statistics. Genomic reads are reads mapping to the 
genome. Genomic reads mapping uniquely are classified in three classes: intronic reads are reads mapping 
entirely within a gene, but not entirely within annotated exons. Exonic reads are reads mapping entirely within 
exons. Intergenic reads are reads not mapping entirely within genes. Junction reads are reads mapping to splice 
junctions but not to the genome. b, Number of genes and transcripts expressed at different expression cutoffs. c, 
Mapping statistics for the ChIPSeq experiments on histone modifications. The genome-wide Pearson 
correlation between WID and EID epigenomes is very high: 0.90 for H3, 0.84 for H3K4me3, 0.94 for H3K9ac, 
0.96 for H3K36me3, 0.92 for H3K4me1 and 0.92 for H3K27ac when computed on the number of reads 
mapping onto 1,000 bp long windows. d, e, Join distribution in WID and EID of gene and transcript expression. 
Expression is measured in log RPKM. f, Gene Ontology term enrichment of 628 genes preferentially expressed 
in EID and 184 genes preferentially expressed in WID. 
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Supplementary Figure 8: Profiles of RNA expression, H3 and histone modifications in WID and 
EID-specific genes. a, Stable gene tio, regulated WID-specific gene Pdm2 and regulated EID-specific gene 
CG34244 are expressed at the same level (green tracks and bottom panel). Histone modifications typical of 
gene activation are observed in tio whereas the tissue-specific genes lack all of them, even in the tissue in which 
they are expressed. b,, Stable gene net, regulated WID-specific gene CG12009 and regulated EID-specific gene 
nerfin-1 are expressed at very similar levels (green tracks and bottom panel), but net exhibits histone 
modifications, whereas the tissue-specific genes lack all of them, even in the tissue in which they are expressed. 
In none of the cases, absence of histone marking cannot be attributed to the lack of nucleosomes because the H3 
signal is comparable in both cases.  
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Supplementary Table 1: Gene and Exon sets. 
 
 
Supplementary Table 2a: Correlation between transcriptional stability (measured as 
coefficient of variation, cv), histone modification levels and gene expression levels. For each gene, we 
compute the cv along the twelve fly developmental time points, and the average expression and histone 
modification levels. The correlation is computed over all genes.   
 
 
 
Supplementary Table 2b: Partial correlations between transcriptional stability (measured as 
coefficient of variation, cv) and histone modification levels, eliminating the effect of gene expression, 
For each gene, we compute the cv along the twelve fly developmental time points, and the average 
expression and histone modficiation levels. To compute the partial correlation between cv and average 
histone modifications, we used the Package GGM, giving the gene expression as controlling variable.  
 
 
 
 
Supplementary references 
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Deep sequencing of subcellular RNA fractions shows splicing to be 
predominantly co-transcriptional in the human genome but inefficient 
for lncRNAs. 
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Promoter-like epigenetic signatures in exons with cell type-specific 
splicing 
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Figure S1. Flowchart of the pipeline employed to define differentially 
included exons between two cell lines 
 
Internal exons were selected based on Gencode 15 annotation. 
Junction reads from RNASeq datasets of the cell types investigated within 
the ENCODE project were used to define the lists of alternative (more and 
less included) and not alternative (notAS) exons for each cell pair. These 
exons were also filtered by expression level changes (CAGE data), 
mappability, inclusion level change and only one per gene was kept. 
Supplementary material – Part III 
 
185 
 
Figure S2. Principal component analysis (PCA) of the differentially 
included exons based on the differential H3K9ac, H3K27ac and 
H3K4me3 ChIPSeq signal. 
  
“Promoter-like” exons are represented in green and the remaining 
differentially included exons in gray. The left and right subgroups of 
“promoter-like” exons, separated by PC1, represent the less and more 
included exons, respectively. 
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Figure S3. Differential inclusion and chromatin levels between K562 
and NHEK 
 
 
 
In the 22 “promoter-like” exons that were regulated between K562 and 
NHEK we calculated the differential inclusion level (in the plot multiplied 
by 100), the differential signal of the H3K9ac, H3K27ac and H3K4me3 
levels and the Total of the three. In the overwhelmingly majority of the 
cases, differential exon inclusion and differential total histone levels are in 
consistent directions.  
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Figure S4. Inclusion levels distribution in tissue samples from GTEx.  
   
       
Inclusion levels for all the identified differentially included exons 
calculated in 1,493 RNASeq samples from the GTEx project. Each exon in 
each sample was categorized based on the inclusion level: low (between 0 
ad 0.1), low-mid (between 0.1 and 0.5), mid-high (between 0.5 and 0.9) 
and high (between 0.9 and 1). Left plot represents “promoter-like” exons, 
right plot represents the remaining differentially included exons. 
“promoter-like” exons non “promoter-like” exons 
100%
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Figure S5. Transcription Factors ChIPSeq signal in “promoter-like” 
exons in C-higher and C-lower condition. 
 
Signals are represented for “promoter-like” and flanking non-differentially 
included exons. Significance levels are indicated by * (0.05>p>0.01), ** 
(0.01>p>0.001), *** (0.001>p) and “ns” (p>0.05) 
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Figure S6. Dnase I sensitivity signal in regulated exons.  
 
 
Signals are represented for regulated and flanking non-regulated exons. 
Significance levels are indicated by * (0.05>p>0.01), ** (0.01>p>0.001), 
*** (0.001>p) and “ns” (p>0.05) 
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Figure S7. Distribution of RNASeq junction reads in promoter like 
exons 
 
  
Signals are represented for “promoter-like” exons in C-higher and C-lower 
conditions. Significance levels are indicated by * (0.05>p>0.01), ** 
(0.01>p>0.001) and “ns” (p>0.05) 
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Figure S8. ChIA-PET signal in regulated exons.  
 
Signals are represented for regulated and flanking non-regulated exons. 
Significance levels are indicated by * (0.05>p>0.01), ** (0.01>p>0.001), 
*** (0.001>p) and “ns” (p>0.05) 
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Table S1. List of primers used for exon inclusion validation 
Primer name sequence 
IFNGR1_dwr GACCTGTGGCATGATCTGGT 
IFNGR1_aef GCAGATGCTTTTGAAGTCACC 
IFNGR1_inclr AACATTAGTTGGTGTAGGCACTCC 
IFNGR1_skippingr ACATTAGTTGGTGTAGGCACTGAG 
RNASET2_upf CAGCTGGCAGCGTTCTCT 
RNASET2_dwr GGCCAGTGCTGAACCATAAT 
RNASET2_skipf CAAGCGCCTGCGTGAC 
Camkk2_inclf TGCCGGAAATCAAGCTG 
Camkk2_inclr AGCGTGCAGTTCTCATCCTC 
Camkk2_skipf TGCCGGAAATCAAGATCC 
Camkk2_skipr GCTGACAGTGAGCGTTCCTC 
Camkk2_dwf TAAACGCTCCTTTGGGAACC 
Camkk2_dwr GCTGACAGTGAGCGTTCCTC 
LSM7_upf GGAGAAGAAGAAAAAGGAGAGC 
LSM7_upr TTTACCCGGATCGTCTTGTC 
LSM7_inclR GGCTAGGGCCTGTGACTCTTC 
LSM7_skiplR CAGGATTCCACTGGCTTCG 
LSM7_dwf GAATCCTGAAGGGCTTCGAC 
LSM7_dwr CTCGCATGTACTCAATGGTG 
LSM7_aef CCTCAGTGCTCACATCTCTCC 
LSM7_aer TGCAGATGTTCAGGTCCTTG 
rab27a_upf TGAAGAGGACATGTGATTGGA 
rab27a_upr ACAGGGTAGAGAACCGCTTG 
rab27a_aef TATCCACGGGCTAGCCATAC 
rab27a_aer TCCTCAGAGTGCTTCAGTGC 
rab27a_dwf TGGGAGACTCTGGTGTAGGG 
rab27a_dwr TCAATGCCCACTGTTGTGATA 
rab27a_inclr GGATAAGGGCAGAGCCTCTTTA 
rab27a_skipf CGGTTCTCTACCCTGTAAAGGTG 
MUYTH_inclr CCAGGGACCTGTATGGGTT 
MUYTH_inclf GCCAGGGACCTGTATGTAGA 
MUYTH_aef AAGTGATCTGCCCATCTTGG 
MUYTH_aer AGAACTGATAGCTCCCATGGAT 
MUYTH_dwf AAAAGGTCCCAGGTGTCCTC 
MUYTH_dwr CTGCACTGTTGAGGCTGTGT 
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ABI1_inclf CAATTTTCTGCTCAGCCTCA 
ABI1_inclr GGGTGGAGCAATAGAAATTGA 
ABI1_skipf TTTTCTGCTCAGCCTCATGTT 
ABI1_skipr GGAGTTGGACTATCAGCAATTGA 
ABI1_dwf CCTCCACCAGATGACATTCC 
ABI1_dwr TGCAGCCTCCTCATCTTCAT 
ERI1_upf GCATGGAGGATCCACAGAGT 
ERI1_dwr AAGTCACTCGCACTGGAGGT 
ERI1_inclf ACGTTGTCAATCTCATCCTGAAAC 
ERI1_skipR ATTTACACTGTTGAGTTTCCTCGG 
USP16_upf ATGAGGGGATGCAGTTATGG 
USP16_dwr TGTCCGTTTCTTTCCCATGT 
USP16_inclf CTCTGTCGCCGTGGGATA 
USP16_aer GAGATCGAGGTGGGAGGAC 
USP16_skipf CTGTCGCCGTGGATTGTT 
thrap3_upf CAGCTGCGATCTCTGTGGTA 
thrap3_dwr CTGGATCCCAGACACTACCC 
thrap3_inclf TCTGTGGTAGGCCCAGTCAA 
thrap3_aer AAAACTGAGGCAGCTGGAGA 
thrap3_skipf TCTGTGGTAGGCCCAGAAGTG 
SRSF6_upf CGAGCGCGTGATCGTAGA 
SRSF6_upr GCGGCTTCCGTAGCTGTAG 
SRSF6_aef TTGTGTGACCCTTGCCCTAT 
SRSF6_aer TCTAATGGCAAAAGGCTGCT 
SRSF6_dwf AAATACGGACCACCTGTTCG 
SRSF6_dwr GCCAACTGCACCGACTAGA 
SRSF6_inclr GCCCCATTGGTCATGC 
SRSF6_skipr TCCACCTCCACCACTGC 
EZH2_9Af TGGGTATATATTGCCTGTTGGA 
EZH2_9Ar CTTCTGCAGGTGCCATTCA 
EZH2_9_10f AGTGTTACCAGCATTTGGAGG 
EZH2_10r ACGTTTTGGTGGGGTCTTTA 
EZH2_9_9Af GCGGAAGAACACAGAAACAG 
EZH2_9_9Ar TCCTAGGTAGGAGTGGCAAA 
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Table S2. List of cell line comparison used  
 
Cell-pair 1 2 3 4 5 
K562 vs Gm12878 YES YES YES YES YES 
K562 vs HelaS3 YES YES YES YES YES 
K562 vs Hepg2 YES YES NO YES YES 
K562 vs Huvec YES YES NO NO YES 
Gm12878 vs 
HelaS3 YES YES YES YES YES 
Gm12878 vs 
Hepg2 YES YES YES YES YES 
Gm12878 vs 
Huvec YES YES YES NO YES 
Huvec vs HelaS3 YES YES YES YES YES 
Huvec vs Hepg2 YES YES YES YES YES 
HelaS3 vs Hepg2 YES YES YES YES YES 
 
Criteria for pairwise AS exons validation 
1 AS exons should have weaker splice sites 
2 AS exons should be smaller 
3 
Conding AS exons should be more often divisible 
by 3 
4 
Both categories should have similar gene 
expression 
5 
Both categories should have no difference in 
mappability 
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Table S3. Number of selected differential included exons 
 
Cell-pair 
More included 
exons 
Less included 
exons 
K562 vs Gm12878 283 227 
K562 vs HelaS3 199 334 
Gm12878 vs HelaS3 208 427 
Gm12878 vs Hepg2 153 296 
Huvec vs HelaS3 369 413 
Huvec vs Hepg2 196 229 
HelaS3 vs Hepg2 276 272 
TOTAL 1684 2198 
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Table S4. List of primers used for H3K9ac validation 
 
tag sequence 
ABI1_11f CTCCCCCTATGCCTCAGTT 
ABI1_11r CACGAAGCCTGTGAGAGGTA 
ABI1_7f CCCCCAACAGTTCCTAATGA 
ABI1_7r GACTTCCAAGCCTAGCAGGA 
EZH2_9Af TGGGTATATATTGCCTGTTGGA 
EZH2_9Ar CTTCTGCAGGTGCCATTCA 
EZH2_9f TTTCATGCAACACCCAACAC 
EZH2_9r GGTCCACAAGGTTTGTTGTCT 
camkk2_16f ACGCTGGTCGAAGTGACTG 
camkk2_16r CAAGCTGGGAATGTGTTTGA 
camkk2_12f GCTGACTTTGGTGTGAGCAA 
camkk2_12r AGAAGATCTTGCGGGTCTCA 
LSM7_aef CCTCAGTGCTCACATCTCTCC 
LSM7_aer TGCAGATGTTCAGGTCCTTG 
LSM7_upf GGAGAAGAAGAAAAAGGAGAGC 
LSM7_upr TTTACCCGGATCGTCTTGTC 
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Table S5. List of RBP binding sites enriched in “promoter-like” exons 
ID RBP name organism db p-value 
RNCMPT00003 aret Drosophila_melanogaster RNAcompete 5.84E-18 
RNCMPT00004 BRUNOL4 Homo_sapiens RNAcompete 8.73E-17 
RNCMPT00011 papi Drosophila_melanogaster RNAcompete 7.60E-15 
RNCMPT00027 HNRNPL Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00051 RBM38 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00069 sm Drosophila_melanogaster RNAcompete 2.15E-10 
RNCMPT00113 RBM4 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00114 aret Drosophila_melanogaster RNAcompete 2.15E-10 
RNCMPT00134 SRSF4 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00150 ESRP2 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00160 HNRNPH2 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00166 CELF3 Homo_sapiens RNAcompete 2.15E-10 
RNCMPT00178 hnRNPLL Homo_sapiens RNAcompete 6.66E-04 
RNCMPT00179 Rbm24 Mus_musculus RNAcompete 8.08E-04 
RNCMPT00216 RRM_1 Trypanosoma_brucei RNAcompete 1.01E-03 
RNCMPT00246 Pcbp4 Mus_musculus RNAcompete 3.33E-03 
RNCMPT00270 aret_CONSTRUCT RNAcompete_CONSTRUCTS RNAcompete 2.89E-02 
RNCMPT00283 Rbm24 Mus_musculus RNAcompete 4.20E-02 
RNCMPT00285 Rbm24 Mus_musculus RNAcompete 4.20E-02 
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Table S6. List of Transcription factor binding sites enriched in 
“promoter-like” exons 
               ID TF name organism db p-vavlue 
MA0472.1 EGR2 Mus_musculus JASPAR core 0.00E+00 
MA0592.1 ESRRA Homo_sapiens JASPAR core 3.69E-04 
MA0599.1 KLF5 Homo_sapiens JASPAR core 6.15E-03 
MA0491.1 JUND Homo_sapiens JASPAR core 1.23E-02 
MA0477.1 FOSL1 Homo_sapiens JASPAR core 2.82E-02 
MA0131.1 HINFP Homo_sapiens JASPAR core 3.74E-02 
MA0470.1 E2F4 Homo_sapiens JASPAR core 3.74E-02 
 
 
 
 
 
 
 
 
 
 
